,datetime,title,source,link,sentiment_class,sentiment_score
0,10/25/2016 10:22:30 PM,BRIEF-ResMed announces results for Q1 of fiscal year 2017 (RMD),Reuters,http://www.businessinsider.com/r-brief-resmed-announces-results-for-q1-of-fiscal-year-2017-2016-10,positive,0.9040272235870361
1,12/1/2016 10:50:03 PM,"BRIEF-Fisher & Paykel Healthcare successful in German court proceedings related to Resmed (FPH, RMD)",Reuters,http://www.businessinsider.com/r-brief-fisher--paykel-healthcare-successful-in-german-court-proceedings-related-to-resmed-2016-12,neutral,0.6052202582359314
2,12/1/2016 11:46:09 PM,"UPDATE 1-Fisher & Paykel wins German court case against ResMed (FPH, RMD)",Reuters,http://www.businessinsider.com/r-update-1-fisher--paykel-wins-german-court-case-against-resmed-2016-12,negative,0.6021537780761719
3,12/2/2016 12:20:09 AM,Fisher & Paykel wins German court case against ResMed,Reuters,http://www.businessinsider.com/r-fisher--paykel-wins-german-court-case-against-resmed-2016-12,neutral,0.6613073945045471
4,12/13/2016 5:14:03 PM,"BRIEF-Richmond Minerals to sell flow-through, hard dollar units (RMD)",Reuters,http://www.businessinsider.com/r-brief-richmond-minerals-to-sell-flow-through-hard-dollar-units-2016-12,positive,0.9179602265357971
5,1/9/2017 4:00:03 PM,"BRIEF-FDA clears world's smallest CPAP, ResMed AirMini (RMD)",Reuters,http://www.businessinsider.com/r-brief-fda-clears-worlds-smallest-cpap-resmed-airmini-2017-1,positive,0.6988776922225952
6,1/21/2017 1:24:09 AM,BRIEF-Resmed and BMC/3B Medical settle global litigation (RMD),Reuters,http://www.businessinsider.com/r-brief-resmed-and-bmc-3b-medical-settle-global-litigation-2017-1,positive,0.9336437582969666
7,1/23/2017 10:40:05 PM,BRIEF-ResMed reports Q2 earnings per share $0.54 (RMD),Reuters,http://www.businessinsider.com/r-brief-resmed-reports-q2-earnings-per-share-054-2017-1,positive,0.8670928478240967
8,3/6/2017 11:20:23 PM,"BRIEF-Richmond Minerals increases non-brokered private placement to $216,000 (RMD)",Reuters,http://www.businessinsider.com/r-brief-richmond-minerals-increases-non-brokered-private-placement-to-216000-2017-3,negative,0.7847229838371277
9,3/20/2017 11:05:00 PM,Research on Treating Sleep Apnea with Adaptive Servo-ventilation Published in the Journal of the American College of Cardiology (JACC),PR Newswire,/news/stocks/research-on-treating-sleep-apnea-with-adaptive-servo-ventilation-published-in-the-journal-of-the-american-college-of-cardiology-jacc-486316,positive,0.9184163212776184
10,4/6/2017 3:00:00 PM,New ResMed-sponsored Study Shows Promising Treatment Option for Patients with Untreated Central Sleep Apnea,PR Newswire,/news/stocks/new-resmed-sponsored-study-shows-promising-treatment-option-for-patients-with-untreated-central-sleep-apnea-1001902814,negative,0.9348105192184448
11,4/6/2017 3:00:00 PM,New ResMed-sponsored Study Shows Promising Treatment Option for Patients with Untreated Central Sleep Apnea,PR Newswire,/news/stocks/new-resmed-sponsored-study-shows-promising-treatment-option-for-patients-with-untreated-central-sleep-apnea-1001902858,negative,0.9348105192184448
12,4/6/2017 3:00:00 PM,New ResMed-sponsored Study Shows Promising Treatment Option for Patients with Untreated Central Sleep Apnea,PR Newswire,/news/stocks/new-resmed-sponsored-study-shows-promising-treatment-option-for-patients-with-untreated-central-sleep-apnea-1001902833,negative,0.9348105192184448
13,4/6/2017 3:00:00 PM,New ResMed-sponsored Study Shows Promising Treatment Option for Patients with Untreated Central Sleep Apnea,PR Newswire,/news/stocks/new-resmed-sponsored-study-shows-promising-treatment-option-for-patients-with-untreated-central-sleep-apnea-1001902810,negative,0.9348105192184448
14,4/6/2017 3:32:50 PM,BRIEF-ResMed provides data on patients with untreated sleep apnea (RMD),Reuters,http://www.businessinsider.com/r-brief-resmed-provides-data-on-patients-with-untreated-sleep-apnea-2017-4,positive,0.9364414811134338
15,4/10/2017 1:00:00 PM,"Research Reports Initiation on Medical Equipment Stocks -- Align, ResMed, Corindus, and Second Sight Medical Products",PR Newswire,/news/stocks/research-reports-initiation-on-medical-equipment-stocks-align-resmed-corindus-and-second-sight-medical-products-1001909882,positive,0.9426506161689758
16,4/25/2017 3:19:00 PM,ResMed Unveils AirMini - the World's Smallest CPAP,PR Newswire,/news/stocks/resmed-unveils-airmini-the-world-s-smallest-cpap-1001946751,positive,0.7023404240608215
17,4/25/2017 3:25:00 PM,ResMed Unveils AirMini - the World's Smallest CPAP,PR Newswire,/news/stocks/resmed-unveils-airmini-the-world-s-smallest-cpap-1001946777,positive,0.7023404240608215
18,4/25/2017 3:29:00 PM,ResMed Unveils AirMini - the World's Smallest CPAP,PR Newswire,/news/stocks/resmed-unveils-airmini-the-world-s-smallest-cpap-1001946781,positive,0.7023404240608215
19,4/25/2017 3:39:00 PM,ResMed Unveils AirMini - the World's Smallest CPAP,PR Newswire,/news/stocks/resmed-unveils-airmini-the-world-s-smallest-cpap-1001946853,positive,0.7023404240608215
20,4/27/2017 10:05:00 PM,ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2017,PR Newswire,/news/stocks/resmed-inc-announces-results-for-the-third-quarter-of-fiscal-year-2017-1001958753,positive,0.8839092254638672
21,4/27/2017 10:31:07 PM,BRIEF-Resmed Q3 gaap earnings per share $0.62 (RMD),Reuters,http://www.businessinsider.com/r-brief-resmed-q3-gaap-earnings-per-share-062-2017-4,positive,0.856707751750946
22,4/28/2017 2:08:25 AM,Resmed Inc Bottom Line Rises 3% In Q3,RTTNews,/news/stocks/resmed-inc-bottom-line-rises-3-in-q3-1001959338,negative,0.9407839179039001
23,5/16/2017 3:00:00 PM,Introducing the Softest CPAP Mask from ResMed,PR Newswire,/news/stocks/introducing-the-softest-cpap-mask-from-resmed-1002017180,positive,0.6860356330871582
24,5/17/2017 2:16:04 AM,"BRIEF-Fisher & Paykel Healthcare Corp says U.S. ITC complaint against Co withdrawn (FPH, RMD)",Reuters,http://www.businessinsider.com/r-brief-fisher--paykel-healthcare-corp-says-us-itc-complaint-against-co-withdrawn-2017-5,positive,0.5564720630645752
25,5/17/2017 4:50:07 AM,"ResMed withdraws U.S. trade complaint against Fisher & Paykel Healthcare (RMD, FPH)",Reuters,http://www.businessinsider.com/r-resmed-withdraws-us-trade-complaint-against-fisher--paykel-healthcare-2017-5,neutral,0.923854410648346
26,5/17/2017 9:58:00 AM,Statement by ResMed on Plans to Renew Its Patent Infringement Case Against Fisher & Paykel,PR Newswire,/news/stocks/statement-by-resmed-on-plans-to-renew-its-patent-infringement-case-against-fisher-paykel-1002019659,positive,0.5758509039878845
27,5/17/2017 10:13:00 AM,Statement by ResMed on Plans to Renew Its Patent Infringement Case Against Fisher & Paykel,PR Newswire,/news/stocks/statement-by-resmed-on-plans-to-renew-its-patent-infringement-case-against-fisher-paykel-1002019763,positive,0.5758509039878845
28,5/17/2017 10:22:00 AM,Statement by ResMed on Plans to Renew Its Patent Infringement Case Against Fisher & Paykel,PR Newswire,/news/stocks/statement-by-resmed-on-plans-to-renew-its-patent-infringement-case-against-fisher-paykel-1002019822,positive,0.5758509039878845
29,5/17/2017 10:23:28 AM,ResMed Plans To Renew Patent Infringement Case Against Fisher & Paykel In ITC ,RTTNews,/news/stocks/resmed-plans-to-renew-patent-infringement-case-against-fisher-paykel-in-itc-1002019780,neutral,0.5335466265678406
30,5/17/2017 11:30:07 AM,"BRIEF-Resmed plans to renew its patent infringement case against Fisher & Paykel (RMD, FPH)",Reuters,http://www.businessinsider.com/r-brief-resmed-plans-to-renew-its-patent-infringement-case-against-fisher--paykel-2017-5,neutral,0.5028871297836304
31,6/22/2017 12:35:00 PM,"Medical Equipment Stock Performance Review -- MiMedx, Stryker, Zimmer Biomet, and ResMed",PR Newswire,/news/stocks/medical-equipment-stock-performance-review-mimedx-stryker-zimmer-biomet-and-resmed-1002115450,positive,0.9258154034614563
32,6/29/2017 10:05:00 PM,ResMed to Announce Fourth Quarter Fiscal Year 2017 Results,PR Newswire,/news/stocks/resmed-to-announce-fourth-quarter-fiscal-year-2017-results-1002136554,positive,0.9387362599372864
33,7/25/2017 4:00:00 PM,"HomeUnion Names 20 Zip Codes With the Highest Real Estate Returns, Lowest Risk",PR Newswire,/news/stocks/homeunion-names-20-zip-codes-with-the-highest-real-estate-returns-lowest-risk-1001883636,positive,0.8777716159820557
34,8/1/2017 10:21:13 PM,Resmed Inc Bottom Line Rises 5% In Q4,RTTNews,/news/stocks/resmed-inc-bottom-line-rises-5-in-q4-1002223919,negative,0.9403843283653259
35,8/1/2017 10:21:43 PM,BRIEF-Resmed Q4 GAAP earnings per share $0.71 (RMD),Reuters,http://www.businessinsider.com/r-brief-resmed-q4-gaap-earnings-per-share-071-2017-8,positive,0.8479086756706238
36,8/3/2017 12:15:00 PM,"Medical Equipment Stock Performance Review -- Align Technology, Invacare, Globus Medical, and ResMed",PR Newswire,/news/stocks/medical-equipment-stock-performance-review-align-technology-invacare-globus-medical-and-resmed-1002229771,positive,0.9328151345252991
37,9/6/2017 12:50:00 PM,"Stocks Under Scanner in the Medical Equipment Space -- Globus Medical, Invacare, ResMed, and Zimmer Biomet",PR Newswire,/news/stocks/stocks-under-scanner-in-the-medical-equipment-space-globus-medical-invacare-resmed-and-zimmer-biomet-1002344747,positive,0.8777762055397034
38,9/25/2017 10:18:00 PM,"Project Update: Farellon Copper-Gold Vein System, Chile",PR Newswire,/news/stocks/project-update-farellon-copper-gold-vein-system-chile-588867,positive,0.936703085899353
39,9/25/2017 11:02:09 PM,BRIEF-Resmed inc says CEO Michael Farrell's FY 2017 total compensation was $8.1 mln vs $7.5 mln in FY 2016 (RMD),Reuters,http://www.businessinsider.com/r-brief-resmed-inc-says-ceo-michael-farrells-fy-2017-total-compensation-was-81-mln-vs-75-mln-in-fy-2016-2017-9,neutral,0.940687894821167
40,9/28/2017 10:05:00 PM,ResMed to Announce First Quarter Fiscal Year 2018 Results,PR Newswire,/news/stocks/resmed-to-announce-first-quarter-fiscal-year-2018-results-1002770803,positive,0.9415072202682495
41,9/28/2017 10:37:18 PM,"BRIEF-Fisher & Paykel Healthcare says German court suspends patent proceedings against co (FPH, RMD)",Reuters,http://www.businessinsider.com/r-brief-fisher--paykel-healthcare-says-german-court-suspends-patent-proceedings-against-co-2017-9,neutral,0.9017514586448669
42,9/28/2017 11:07:15 PM,"German court suspends Resmed's complaint against NZ's Fisher & Paykel (RMD, FPH)",Reuters,http://www.businessinsider.com/r-german-court-suspends-resmeds-complaint-against-nzs-fisher--paykel-2017-9,neutral,0.9061274528503418
43,9/29/2017 12:17:14 AM,"UPDATE 1-German court suspends Resmed's complaint against NZ's Fisher & Paykel (RMD, FPH)",Reuters,http://www.businessinsider.com/r-update-1-german-court-suspends-resmeds-complaint-against-nzs-fisher--paykel-2017-9,neutral,0.926701545715332
44,9/29/2017 2:00:00 PM,Canadian Airports Safety Week Underway at Airports Across Canada Next Week,PR Newswire,/news/stocks/canadian-airports-safety-week-underway-at-airports-across-canada-next-week-456725,positive,0.9190689325332642
45,10/2/2017 6:28:00 PM,SLAM Acquires Cobalt Property,PR Newswire,/news/stocks/slam-acquires-cobalt-property-452663,positive,0.9348946809768677
46,10/3/2017 1:00:00 PM,Arianne expands the role of two directors - Dominique Bouchard moves to Executive Vice Chairman,PR Newswire,/news/stocks/arianne-expands-the-role-of-two-directors-dominique-bouchard-moves-to-executive-vice-chairman-455622,positive,0.8978586196899414
47,10/3/2017 4:00:00 PM,Montreal startup Soul.City launches its city discovery app in New York and San Francisco!,PR Newswire,/news/stocks/montreal-startup-soul-city-launches-its-city-discovery-app-in-new-york-and-san-francisco!-519678,positive,0.6509197354316711
48,10/4/2017 10:00:00 PM,Paul Carreiro Joins Kinaxis as Chief Revenue Officer,PR Newswire,/news/stocks/paul-carreiro-joins-kinaxis-as-chief-revenue-officer-452385,positive,0.9249626994132996
49,10/6/2017 10:53:00 AM,ResMed's European Patents Infringed by Fisher & Paykel in Germany,PR Newswire,/news/stocks/resmed-s-european-patents-infringed-by-fisher-paykel-in-germany-1003159538,neutral,0.895659327507019
50,10/6/2017 10:53:00 AM,ResMed's European Patents Infringed by Fisher & Paykel in Germany,PR Newswire,/news/stocks/resmed-s-european-patents-infringed-by-fisher-paykel-in-germany-1001745294,neutral,0.895659327507019
51,10/6/2017 11:15:00 AM,ResMed's European Patents Infringed by Fisher & Paykel in Germany,PR Newswire,/news/stocks/resmed-s-european-patents-infringed-by-fisher-paykel-in-germany-1003160999,neutral,0.895659327507019
52,10/6/2017 11:15:55 AM,ResMed: German Court Concludes Fisher Infringes Two ResMed European Patents ,RTTNews,/news/stocks/resmed-german-court-concludes-fisher-infringes-two-resmed-european-patents-1003160296,neutral,0.9312067031860352
53,10/6/2017 11:19:00 AM,ResMed's European Patents Infringed by Fisher & Paykel in Germany,PR Newswire,/news/stocks/resmed-s-european-patents-infringed-by-fisher-paykel-in-germany-1003161003,neutral,0.895659327507019
54,10/6/2017 11:36:00 AM,ResMed's European Patents Infringed by Fisher & Paykel in Germany,PR Newswire,/news/stocks/resmed-s-european-patents-infringed-by-fisher-paykel-in-germany-1002070281,neutral,0.895659327507019
55,10/9/2017 2:57:05 AM,"BRIEF-Resmed ‍says German court concludes two of co's European patents have been infringed​ (RMD, FPH)",Reuters,http://www.businessinsider.com/r-brief-resmed-says-german-court-concludes-two-of-cos-european-patents-have-been-infringed-2017-10,neutral,0.9386403560638428
56,10/12/2017 5:57:03 PM,BRIEF-RESMED WINS GERMAN PATENT INFRINGEMENT CASE BROUGHT BY FISHER & PAYKEL (RMD),Reuters,http://www.businessinsider.com/r-brief-resmed-wins-german-patent-infringement-case-brought-by-fisher--paykel-2017-10,neutral,0.8475760817527771
57,10/13/2017 8:01:32 AM,"ONCE Sparkles, BDSI Makes Peace, Coming Event Casts Its Shadow Before ATRS ",RTTNews,/news/stocks/once-sparkles-bdsi-makes-peace-coming-event-casts-its-shadow-before-atrs-1004091271,positive,0.8600578904151917
58,10/16/2017 4:15:00 PM,Minister MacAulay Takes Part in World Food Day,PR Newswire,/news/stocks/minister-macaulay-takes-part-in-world-food-day-1001551235,positive,0.9179936051368713
59,10/17/2017 3:35:00 PM,Top 20 U.S. Dividend Trust Announces Minimum Unit Condition Has Been Satisfied,PR Newswire,/news/stocks/top-20-u-s-dividend-trust-announces-minimum-unit-condition-has-been-satisfied-534920,positive,0.8143182992935181
60,10/18/2017 3:00:00 PM,Richmond Minerals Inc. Continues to Intersect Broad Zones of Gold Mineralization in Phase 3 Diamond Drilling,PR Newswire,/news/stocks/richmond-minerals-inc-continues-to-intersect-broad-zones-of-gold-mineralization-in-phase-3-diamond-drilling-1004769356,negative,0.7061969041824341
61,10/20/2017 7:20:00 PM,Prometic presents PBI-4050 and PBI-4547 in Vivo Data at American Association for the Study of Liver Diseases (AASLD) Meeting,PR Newswire,/news/stocks/prometic-presents-pbi-4050-and-pbi-4547-in-vivo-data-at-american-association-for-the-study-of-liver-diseases-aasld-meeting-542665,positive,0.9047702550888062
62,10/25/2017 7:00:00 AM,ResMed AirFit N20 Classic CPAP Mask Launches in Europe,PR Newswire,/news/stocks/resmed-airfit-n20-classic-cpap-mask-launches-in-europe-1001790401,positive,0.7309472560882568
63,10/26/2017 10:05:00 PM,ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2018,PR Newswire,/news/stocks/resmed-inc-announces-results-for-the-first-quarter-of-fiscal-year-2018-1005744001,positive,0.8889251351356506
64,10/26/2017 10:57:08 PM,BRIEF-Resmed Inc reports Q1 earnings $0.60/shr (RMD),Reuters,http://www.businessinsider.com/r-brief-resmed-inc-reports-q1-earnings-060-shr-2017-10,positive,0.6750342845916748
65,10/26/2017 11:19:55 PM,Resmed Inc Reports 7% Increase In Q1 Bottom Line,RTTNews,/news/stocks/resmed-inc-reports-7-increase-in-q1-bottom-line-1005749925,negative,0.9407588243484497
66,11/3/2017 11:00:00 AM,GMP Capital Inc. Reports Third Quarter 2017 Results,PR Newswire,/news/stocks/gmp-capital-inc-reports-third-quarter-2017-results-490517,positive,0.8337677121162415
67,11/6/2017 3:00:00 PM,"ResMed Adds Remote Patient Monitoring to AirMini, World's Smallest CPAP",PR Newswire,/news/stocks/resmed-adds-remote-patient-monitoring-to-airmini-worlds-smallest-cpap-453813,positive,0.5108129978179932
68,11/6/2017 3:00:00 PM,"ResMed Adds Remote Patient Monitoring to AirMini, World's Smallest CPAP",PR Newswire,/news/stocks/resmed-adds-remote-patient-monitoring-to-airmini-world-s-smallest-cpap-1007060741,positive,0.5108129978179932
69,11/6/2017 3:00:00 PM,"ResMed Adds Remote Patient Monitoring to AirMini, World's Smallest CPAP",PR Newswire,/news/stocks/resmed-adds-remote-patient-monitoring-to-airmini-world-s-smallest-cpap-1007060745,positive,0.5108129978179932
70,11/6/2017 3:00:00 PM,"ResMed Adds Remote Patient Monitoring to AirMini, World's Smallest CPAP",PR Newswire,/news/stocks/resmed-adds-remote-patient-monitoring-to-airmini-world-s-smallest-cpap-1007060771,positive,0.5108129978179932
71,11/6/2017 3:00:00 PM,"ResMed Adds Remote Patient Monitoring to AirMini, World's Smallest CPAP",PR Newswire,/news/stocks/resmed-adds-remote-patient-monitoring-to-airmini-world-s-smallest-cpap-1007060742,positive,0.5108129978179932
72,11/6/2017 3:47:03 PM,"BRIEF-Resmed Inc ‍announces that AirMini, world's smallest pap device is now connected to AirView​ (RMD)",Reuters,http://www.businessinsider.com/r-brief-resmed-inc-announces-that-airmini-worlds-smallest-pap-device-is-now-connected-to-airview-2017-11,positive,0.7679064273834229
73,11/10/2017 3:00:00 PM,SleepScore Labs Launches the World's Most Advanced Sleep Improvement System,PR Newswire,/news/stocks/sleepscore-labs-launches-the-world-s-most-advanced-sleep-improvement-system-1007556507,negative,0.6121479868888855
74,11/11/2017 1:01:00 AM,"Lifshitz & Miller LLP Announces Investigation of Calpine Corporation, Deltic Timber Corporation, FactSet Research Systems Inc., Intel Corporation, Norwegian Cruise Line Holdings Ltd., ResMed Inc.",PR Newswire,/news/stocks/lifshitz-miller-llp-announces-investigation-of-calpine-corporation-deltic-timber-corporation-factset-research-systems-inc-intel-corporation-norwegian-cruise-line-holdings-ltd-resmed-inc-1007609056,positive,0.49388471245765686
75,11/12/2017 9:47:03 PM,"BRIEF-Fisher & Paykel Healthcare Corporation ‍says wins patent case against ResMed in UK court​ (FPH, RMD)",Reuters,http://www.businessinsider.com/r-brief-fisher--paykel-healthcare-corporation-says-wins-patent-case-against-resmed-in-uk-court-2017-11,negative,0.6143040657043457
76,11/12/2017 10:02:03 PM,"Fisher & Paykel says UK court rules rival Resmed's patent is invalid (RMD, FPH)",Reuters,http://www.businessinsider.com/r-fisher--paykel-says-uk-court-rules-rival-resmeds-patent-is-invalid-2017-11,neutral,0.8021665215492249
77,11/12/2017 11:12:05 PM,"UPDATE 1-Fisher & Paykel says UK court rules rival Resmed's patent is invalid (FPH, RMD)",Reuters,http://www.businessinsider.com/r-update-1-fisher--paykel-says-uk-court-rules-rival-resmeds-patent-is-invalid-2017-11,neutral,0.8262457847595215
78,11/13/2017 2:32:03 AM,"BRIEF-Resmed updates on United Kingdom case with Fisher & Paykel​ (RMD, FPH)",Reuters,http://www.businessinsider.com/r-brief-resmed-updates-on-united-kingdom-case-with-fisher--paykel-2017-11,positive,0.9336112141609192
79,11/13/2017 2:54:19 AM,ResMed Says Considers Appeal On U.K. Case With Fisher & Paykel ,RTTNews,/news/stocks/resmed-says-considers-appeal-on-u-k-case-with-fisher-paykel-1007823113,positive,0.4539279639720917
80,11/17/2017 3:00:00 PM,ResMed Elects Karen Drexler to Its Board of Directors,PR Newswire,/news/stocks/resmed-elects-karen-drexler-to-its-board-of-directors-1008432667,positive,0.9365290999412537
81,11/17/2017 3:00:00 PM,ResMed Elects Karen Drexler to Its Board of Directors,PR Newswire,/news/stocks/resmed-elects-karen-drexler-to-its-board-of-directors-1008432671,positive,0.9365290999412537
82,11/17/2017 3:00:00 PM,ResMed Elects Karen Drexler to Its Board of Directors,PR Newswire,/news/stocks/resmed-elects-karen-drexler-to-its-board-of-directors-1008432665,positive,0.9365290999412537
83,11/17/2017 3:00:00 PM,ResMed Elects Karen Drexler to Its Board of Directors,PR Newswire,/news/stocks/resmed-elects-karen-drexler-to-its-board-of-directors-1008432657,positive,0.9365290999412537
84,11/17/2017 3:00:00 PM,ResMed Elects Karen Drexler to Its Board of Directors,PR Newswire,/news/stocks/resmed-elects-karen-drexler-to-its-board-of-directors-1008432685,positive,0.9365290999412537
85,11/17/2017 3:27:05 PM,BRIEF-Resmed Inc elects Karen Drexler to its board of directors (RMD),Reuters,http://www.businessinsider.com/r-brief-resmed-inc-elects-karen-drexler-to-its-board-of-directors-2017-11,positive,0.9373389482498169
86,11/22/2017 8:00:00 AM,Symbility Solutions to Announce Q3 2017 Financial Results,PR Newswire,/news/stocks/symbility-solutions-to-announce-q3-2017-financial-results-590918,positive,0.8576772809028625
87,11/28/2017 4:09:00 PM,Deep Down Receives Subsea Equipment Orders Valued at Over $4 Million,PR Newswire,/news/stocks/deep-down-receives-subsea-equipment-orders-valued-at-over-4-million-1002223850,negative,0.6882886290550232
88,11/30/2017 11:01:00 PM,"Richmond Minerals Inc. Completes $332,887 Non-Brokered Private Placement",PR Newswire,/news/stocks/richmond-minerals-inc-completes-332-887-non-brokered-private-placement-1010104107,positive,0.8886990547180176
89,12/11/2017 3:02:00 PM,SleepScore Enlists Surf Legend Laird Hamilton as Brand Ambassador,PR Newswire,/news/stocks/sleepscore-enlists-surf-legend-laird-hamilton-as-brand-ambassador-580093,positive,0.6084443926811218
90,12/12/2017 2:37:04 AM,"NZ's Fisher & Paykel sues Resmed in patent dispute (FPH, RMD)",Reuters,http://www.businessinsider.com/r-nzs-fisher--paykel-sues-resmed-in-patent-dispute-2017-12,neutral,0.9038745760917664
91,12/12/2017 3:32:03 AM,"UPDATE 1-NZ's Fisher & Paykel sues Resmed in Australia over patent dispute (FPH, RMD)",Reuters,http://www.businessinsider.com/r-update-1-nzs-fisher--paykel-sues-resmed-in-australia-over-patent-dispute-2017-12,neutral,0.9385803937911987
92,12/18/2017 2:00:00 PM,SmartDrive Named to Food Logistics' 2017 FL100+ Top Software and Technology Providers List,PR Newswire,/news/stocks/smartdrive-named-to-food-logistics-2017-fl100+-top-software-and-technology-providers-list-600398,negative,0.8127132058143616
93,12/21/2017 10:30:00 PM,Lucky Minerals welcomes João Carrêlo as Chairman of its Board of Directors,PR Newswire,/news/stocks/lucky-minerals-welcomes-joao-carrelo-as-chairman-of-its-board-of-directors-1001550003,positive,0.8312723636627197
94,1/3/2018 3:00:00 PM,"Diagnosing, Treating Sleep Apnea in Hospital Improves Survival, Says Study Published by American Journal of Medicine",PR Newswire,/news/stocks/diagnosing-treating-sleep-apnea-in-hospital-improves-survival-says-study-published-by-american-journal-of-medicine-1012434779,negative,0.91881263256073
95,1/3/2018 3:00:00 PM,"Diagnosing, Treating Sleep Apnea in Hospital Improves Survival, Says Study Published by American Journal of Medicine",PR Newswire,/news/stocks/diagnosing-treating-sleep-apnea-in-hospital-improves-survival-says-study-published-by-american-journal-of-medicine-1012434760,negative,0.91881263256073
96,1/3/2018 3:00:00 PM,"Diagnosing, Treating Sleep Apnea in Hospital Improves Survival, Says Study Published by American Journal of Medicine",PR Newswire,/news/stocks/diagnosing-treating-sleep-apnea-in-hospital-improves-survival-says-study-published-by-american-journal-of-medicine-1012434754,negative,0.91881263256073
97,1/3/2018 3:00:00 PM,"Diagnosing, Treating Sleep Apnea in Hospital Improves Survival, Says Study Published by American Journal of Medicine",PR Newswire,/news/stocks/diagnosing-treating-sleep-apnea-in-hospital-improves-survival-says-study-published-by-american-journal-of-medicine-1012434744,negative,0.91881263256073
98,1/3/2018 3:00:00 PM,"Diagnosing, Treating Sleep Apnea in Hospital Improves Survival, Says Study Published by American Journal of Medicine",PR Newswire,/news/stocks/diagnosing-treating-sleep-apnea-in-hospital-improves-survival-says-study-published-by-american-journal-of-medicine-1002307708,negative,0.91881263256073
99,1/3/2018 10:33:00 PM,ResMed to Announce Second Quarter Fiscal Year 2018 Results,PR Newswire,/news/stocks/resmed-to-announce-second-quarter-fiscal-year-2018-results-1012446936,positive,0.9414734840393066
100,1/8/2018 3:00:00 PM,"ResMed Announces Its Premier Portable Oxygen Concentrator, Mobi",PR Newswire,/news/stocks/resmed-announces-its-premier-portable-oxygen-concentrator-mobi-1002346938,negative,0.5925797820091248
101,1/19/2018 5:52:00 PM,Liberty Mutual Insurance Realigns Domestic and Global Property & Casualty Operations,PR Newswire,/news/stocks/liberty-mutual-insurance-realigns-domestic-and-global-property-casualty-operations-1002019728,positive,0.9483031630516052
102,1/22/2018 10:05:00 PM,ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2018,PR Newswire,/news/stocks/resmed-inc-announces-results-for-the-second-quarter-of-fiscal-year-2018-1013631094,positive,0.8856252431869507
103,1/22/2018 10:14:56 PM,Resmed Inc Earnings Rise 39% In Q2,RTTNews,/news/stocks/resmed-inc-earnings-rise-39-in-q2-1013631110,negative,0.9422807097434998
104,1/22/2018 10:37:36 PM,ResMed Reports Impact Of U.S. Tax Reform On Income Tax Expense - Quick Facts ,RTTNews,/news/stocks/resmed-reports-impact-of-u-s-tax-reform-on-income-tax-expense-quick-facts-1013632821,positive,0.7553185224533081
105,1/23/2018 6:51:09 AM,"AMGN's LIBERTY Meets Goals, ANTH Yields RESULT, CCXI Up On Cancer Trial Data ",RTTNews,/news/stocks/amgn-s-liberty-meets-goals-anth-yields-result-ccxi-up-on-cancer-trial-data-1013673586,negative,0.9200409054756165
106,1/23/2018 4:30:00 PM,Piper-Heidsieck Champagne Returns For 90th Oscars®,PR Newswire,/news/stocks/piper-heidsieck-champagne-returns-for-90th-oscars-1001687037,negative,0.6579465270042419
107,2/7/2018 5:36:00 PM,GEMCO Medical Announces Brightree Partnership,PR Newswire,/news/stocks/gemco-medical-announces-brightree-partnership-1015056415,positive,0.8802074193954468
108,2/28/2018 2:55:00 PM,Brightree Showcasing Next-Generation Interoperability Experiences at HIMSS18,PR Newswire,/news/stocks/brightree-showcasing-next-generation-interoperability-experiences-at-himss18-1017439091,positive,0.7074139714241028
109,4/2/2018 3:08:26 PM,BRIEF-ResMed Hires Bobby Ghoshal As First Chief Technology Officer,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/qCyy4eHz4Zo/brief-resmed-hires-bobby-ghoshal-as-first-chief-technology-officer-idUSASC09UHG,positive,0.9204895496368408
110,4/19/2018 11:34:18 PM,"BRIEF-Resmed Says Co Entered Certain Amended And Restated Credit Agreement, Dated As Of Closing Date",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/4BIDm5_tFo0/brief-resmed-says-co-entered-certain-amended-and-restated-credit-agreement-dated-as-of-closing-date-idUSFWN1RW0WW,positive,0.9345805644989014
111,4/26/2018 10:51:00 PM,BRIEF-Resmed Inc Q3 GAAP Earnings Per Share $0.76,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/VsCLF0ciWt4/brief-resmed-inc-q3-gaap-earnings-per-share-0-76-idUSASC09XUP,positive,0.6682292819023132
112,4/26/2018 11:28:09 PM,Resmed Inc Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/resmed-inc-q3-adjusted-earnings-beat-estimates-1022454954,negative,0.8399237394332886
113,4/27/2018 3:18:16 PM,"Interesting Stocks To Watch: April 27 (AMZN, SBUX, KLAC, SKYW, BJRI) ",RTTNews,/news/stocks/interesting-stocks-to-watch-april-27-amzn-sbux-klac-skyw-bjri-1022546162,positive,0.9423831105232239
114,5/20/2018 11:28:16 PM,"ResMed: Studies Show Combining Home Oxygen, Home NIV Treatment For COPD ",RTTNews,/news/stocks/resmed-studies-show-combining-home-oxygen-home-niv-treatment-for-copd-1025061215,negative,0.783501386642456
115,5/30/2018 3:04:00 PM,Orienbank The Largest Private Bank in Central Asia and Heaven Springs Dynasty Harvest Group Jointly Develop Atmospheric Water Generation and Sarez Lake,PR Newswire,/news/stocks/orienbank-the-largest-private-bank-in-central-asia-and-heaven-springs-dynasty-harvest-group-jointly-develop-atmospheric-water-generation-and-sarez-lake-1001744941,positive,0.8582122921943665
116,8/1/2018 3:03:01 PM,Here's what Wall Street expects from ResMed's earnings report,Markets Insider Automation,/news/stocks/resmed-q4-earnings-preview-1027421552,positive,0.9185999631881714
117,8/2/2018 11:01:01 PM,Resmed Inc Q4 adjusted earnings Inline With Estimates,RTTNews,/news/stocks/resmed-inc-q4-adjusted-earnings-inline-with-estimates-1027427939,positive,0.7972705364227295
118,9/2/2018 11:19:45 PM,UPDATE 1-NZ's Fisher & Paykel cuts FY guidance on ResMed-linked legal costs,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/C8oWIHTKDEI/update-1-nzs-fisher-paykel-cuts-fy-guidance-on-resmed-linked-legal-costs-idUSL3N1VO0D1,neutral,0.9561024904251099
119,9/10/2018 11:41:39 PM,NZ's Fisher & Paykel Healthcare files patent infringement complaint against ResMed,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/tUDMFn5bI3A/nzs-fisher-paykel-healthcare-files-patent-infringement-complaint-against-resmed-idUSL3N1VW5FX,neutral,0.9237709641456604
120,9/11/2018 12:06:34 AM,UPDATE 1-NZ's Fisher & Paykel Healthcare files complaint in the U.S. against Resmed,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/PXX3BqMYPmU/update-1-nzs-fisher-paykel-healthcare-files-complaint-in-the-u-s-against-resmed-idUSL3N1VW5G7,neutral,0.9444867968559265
121,10/6/2018 2:04:35 AM,USITC to investigate Resmed for alleged patent infringement,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/6Vu90HtaZho/usitc-to-investigate-resmed-for-alleged-patent-infringement-idUSL2N1WM002,positive,0.6357156038284302
122,10/23/2018 8:43:01 AM,"ABBV ACHIEVES Goals, HealthStream's CFO Resigns, NTEC On Watch ",RTTNews,/news/stocks/abbv-achieves-goals-healthstream-s-cfo-resigns-ntec-on-watch-1027642313,neutral,0.688109278678894
123,10/24/2018 3:02:29 PM,Here's what to expect from ResMed's earnings report,Markets Insider Automation,/news/stocks/resmed-quarter-earnings-preview-q1-1027649831,positive,0.931972086429596
124,10/25/2018 10:57:55 PM,Resmed Inc Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/resmed-inc-q1-adjusted-earnings-beat-estimates-1027657085,negative,0.8655866384506226
125,11/5/2018 3:19:24 PM,ResMed To Acquire MatrixCare For $750 Mln ,RTTNews,/news/stocks/resmed-to-acquire-matrixcare-for-750-mln-1027691737,positive,0.9142137765884399
126,1/7/2019 11:29:34 PM,ResMed Completes $225 Mln Acquisition Of Propeller Health ,RTTNews,/news/stocks/resmed-completes-225-mln-acquisition-of-propeller-health-1027849365,positive,0.8165628910064697
127,1/23/2019 3:01:34 PM,Here's what Wall Street expects from ResMed's earnings,Markets Insider Automation,/news/stocks/resmed-stock-q2-earnings-preview-1027889673,positive,0.932039201259613
128,1/24/2019 10:18:44 PM,Resmed Inc Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/resmed-inc-q2-adjusted-earnings-beat-estimates-1027894745,negative,0.852929949760437
129,2/20/2019 9:09:02 PM,NZ's Fisher & Paykel and ResMed settle global patent disputes,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/ZQTFU77xcXA/nzs-fisher-paykel-and-resmed-settle-global-patent-disputes-idUSL3N20F52T,positive,0.8939657211303711
130,2/21/2019 2:14:08 AM,"UPDATE 1-Fisher & Paykel, ResMed settle global patent disputes; shares jump",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/4D2HqSHhvJ4/update-1-fisher-paykel-resmed-settle-global-patent-disputes-shares-jump-idUSL3N20G028,positive,0.731086015701294
131,4/30/2019 3:02:46 PM,Here's what to expect from ResMed's earnings report,Markets Insider Automation,/news/stocks/resmed-q3-quarterly-earnings-preview-stock-1028153747,positive,0.931972086429596
132,5/2/2019 10:38:47 PM,Resmed Inc Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/resmed-inc-q3-adjusted-earnings-beat-estimates-1028163814,negative,0.8399237394332886
133,7/23/2019 3:02:02 PM,ResMed earnings preview: what to expect,Markets Insider Automation,/news/stocks/resmed-quarter-earnings-preview-q4-1028376191,positive,0.9064379334449768
134,10/24/2019 10:20:40 PM,Resmed Inc Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/resmed-inc-q1-adjusted-earnings-beat-estimates-1028629388,negative,0.8655866384506226
135,11/19/2019 3:40:05 PM,The 9 Best Stocks to Buy for the Next Decade,InvestorPlace,/news/stocks/the-10-best-stocks-to-buy-for-the-next-decade-1028275519,positive,0.8352261185646057
136,1/17/2020 7:20:36 AM,ResMed To Pay $37.5 Mln To Settle Kickback Allegations ,RTTNews,/news/stocks/resmed-to-pay-37-5-mln-to-settle-kickback-allegations-1028825232,positive,0.8786643147468567
137,1/29/2020 3:02:11 PM,Here's what Wall Street expects from ResMed's earnings,Markets Insider Automation,/news/stocks/resmed-stock-q2-earnings-preview-1028855162,positive,0.932039201259613
138,1/31/2020 2:32:12 AM,ResMed Q2 Profit Rises ,RTTNews,/news/stocks/resmed-q2-profit-rises-1028861889,negative,0.5228308439254761
139,3/9/2020 4:03:25 PM,7 Healthcare Stocks Worth Your Time Now,InvestorPlace,/news/stocks/7-healthcare-stocks-worth-your-time-now-1028977646,positive,0.8967262506484985
140,4/2/2020 8:13:07 PM,President invokes DPA on more companies for ventilator production,Seeking Alpha,https://seekingalpha.com/news/3557987-president-invokes-dpa-on-companies-for-ventilator-production?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7769989371299744
141,4/6/2020 6:33:31 PM,One ‘Coronavirus’ Stock That Continues to Outperform,InvestorPlace,/news/stocks/resmed-rmd-coronavirus-stock-that-continues-to-outperform-1029069272,negative,0.8478436470031738
142,4/7/2020 5:18:23 PM,3 Ventilator Stocks to Buy for the Coronavirus Crisis,InvestorPlace,/news/stocks/3-ventilator-stocks-to-buy-for-the-coronavirus-crisis-1029073087,positive,0.8979044556617737
143,4/29/2020 3:02:39 PM,ResMed is about to announce earnings — here's what Wall Street expects,Markets Insider Automation,/news/stocks/resmed-q3-earnings-preview-stock-1029144845,positive,0.9360715746879578
144,4/30/2020 8:09:11 PM,"ResMed EPS beats by $0.21, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3567205-resmed-eps-beats-0_21-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8184032440185547
145,4/30/2020 9:54:20 PM,"WDC, SWN, MTZ and RMD among after-hours movers",Seeking Alpha,https://seekingalpha.com/news/3567419-wdc-swn-mtz-and-rmd-among-after-hours-movers?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9376806020736694
146,4/30/2020 11:13:44 PM,Resmed Inc Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/resmed-inc-q3-adjusted-earnings-beat-estimates-1029153818,negative,0.8399237394332886
147,5/1/2020 11:42:18 AM,Guggenheim likes Seattle Genetics in premarket analyst action,Seeking Alpha,https://seekingalpha.com/news/3567579-guggenheim-likes-seattle-genetics-in-premarket-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8452631831169128
148,5/4/2020 11:24:44 AM,"3 Big Stock Charts for Monday: Clorox, Newmont, and ResMed",InvestorPlace,/news/stocks/3-big-stock-charts-for-monday-clorox-newmont-and-resmed-1029159858,positive,0.903096616268158
149,5/5/2020 1:56:51 PM,ResMed launches remote monitoring software for ventilators in Europe,Seeking Alpha,https://seekingalpha.com/news/3569132-resmed-launches-remote-monitoring-software-for-ventilators-in-europe?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8112149238586426
150,6/2/2020 7:58:33 PM,Needham survey tackles home medical equipment expectations,Seeking Alpha,https://seekingalpha.com/news/3579796-needham-survey-tackles-home-medical-equipment-expectations?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8565873503684998
151,8/4/2020 3:03:46 PM,Here's what Wall Street expects from ResMed's earnings,Markets Insider Automation,/news/stocks/resmed-stock-quarter-earnings-preview-q4-1029467162,positive,0.932039201259613
152,8/5/2020 10:12:57 PM,Resmed Inc Q4 adjusted earnings Beat Estimates,RTTNews,/news/stocks/resmed-inc-q4-adjusted-earnings-beat-estimates-1029474918,negative,0.8866145610809326
153,10/28/2020 3:04:56 PM,ResMed earnings preview: what Wall Street is expecting,Markets Insider Automation,/news/stocks/resmed-quarter-earnings-preview-q1-1029734512,positive,0.9105846285820007
154,10/28/2020 5:11:45 PM,ResMed FQ1 2021 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3627428-resmed-fq1-2021-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6729750633239746
155,10/29/2020 9:32:55 PM,Resmed Inc Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/resmed-inc-q1-adjusted-earnings-beat-estimates-1029743805,negative,0.8655866384506226
156,10/30/2020 2:28:46 PM,"ResMed share +5.8%, FQ1 revenue driven by demand for mask product portfolio and  ventilators",Seeking Alpha,https://seekingalpha.com/news/3629134-resmed-shareplus-5_8-fq1-revenue-driven-demand-for-mask-product-portfolio-and-ventilators?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5360882878303528
157,11/9/2020 5:20:21 PM,ResMed goes ex-dividend tomorrow,Seeking Alpha,https://seekingalpha.com/news/3633789-resmed-goes-ex-dividend-tomorrow?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7853865027427673
158,1/23/2021 3:14:04 PM,"The Week Ahead In Biotech (Jan 24-30): J&J, Lilly to Kickstart Big Pharma Earnings, Amgen FDA Decision and More",Benzinga,/news/stocks/the-week-ahead-in-biotech-jan-24-30-j-j-lilly-to-kickstart-big-pharma-earnings-amgen-fda-decision-and-more-1029996049,negative,0.6939177513122559
159,1/26/2021 3:01:42 PM,ResMed earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/resmed-stock-price-q2-earnings-preview-1030004372,positive,0.9339683651924133
160,1/27/2021 6:23:22 PM,ResMed FQ2 2021 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3655021-resmed-fq2-2021-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6140490770339966
161,1/27/2021 10:35:08 PM,Notable earnings after Thursday's close,Seeking Alpha,https://seekingalpha.com/news/3654993-notable-earnings-after-thursdays-close?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8900269269943237
162,1/28/2021 2:03:49 PM,"The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-decision-day-for-amgen-zymeworks-sinks-on-data-ortho-clinical-diagnostics-ipo-1030014922,positive,0.9371458292007446
163,1/28/2021 9:06:45 PM,"ResMed EPS beats by $0.13, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3655785-resmed-eps-beats-0_13-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.798479437828064
164,1/28/2021 9:09:52 PM,ResMed declares $0.39 dividend,Seeking Alpha,https://seekingalpha.com/news/3655789-resmed-declares-0_39-dividend?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9441128373146057
165,1/28/2021 10:13:51 PM,Resmed Inc Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/resmed-inc-q2-adjusted-earnings-beat-estimates-1030017273,negative,0.852929949760437
166,3/8/2021 1:13:12 PM,Struggling defensive sectors losing even more appeal ahead of more stimulus: At the Open,Seeking Alpha,https://seekingalpha.com/news/3670158-struggling-defensive-sectors-losing-even-more-appeal?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.882236659526825
167,3/12/2021 4:43:05 PM,7 Healthcare Stocks to Buy and Hold for the Long Term,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-and-hold-for-the-long-term-1030180655,positive,0.9046281576156616
168,3/16/2021 12:05:44 PM,Biogen expected to receive FDA nod for Alzheimer’s therapy and Solid Bioscience upgraded in today’s analyst action,Seeking Alpha,https://seekingalpha.com/news/3673052-biogen-expected-to-receive-fda-nod-for-alzheimers-therapy?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7139160633087158
169,3/16/2021 3:38:12 PM,"Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-march-16-2021-1030215648,neutral,0.6266746520996094
170,3/16/2021 9:00:32 PM,ResMed expected to beat consensus in upcoming quarters: Needham,Seeking Alpha,https://seekingalpha.com/news/3673389-resmed-expected-to-beat-consensus-in-upcoming-quarters?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.893305242061615
171,4/8/2021 10:05:00 PM,"ResMed to Report Third Quarter Fiscal 2021 Earnings on April 29, 2021",GlobeNewswire,/news/stocks/resmed-to-report-third-quarter-fiscal-2021-earnings-on-april-29-2021-1030287314,positive,0.934674859046936
172,4/24/2021 3:24:00 PM,"The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx",Benzinga,/news/stocks/the-week-ahead-in-biotech-april-25-may-1-fda-decisions-for-sol-gel-protalix-bio-ardelyx-1030340692,positive,0.9154146313667297
173,4/27/2021 3:00:00 PM,ResMed Announces Participation in the 23rd Annual Macquarie Australia Conference,GlobeNewswire,/news/stocks/resmed-announces-participation-in-the-23rd-annual-macquarie-australia-conference-1030352153,positive,0.7810276746749878
174,4/27/2021 3:02:23 PM,ResMed earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/resmed-quarter-earnings-preview-q3-1030351973,positive,0.9339683651924133
175,4/28/2021 9:35:56 PM,ResMed FQ3 2021 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3687025-resmed-fq3-2021-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7159488201141357
176,4/29/2021 2:15:50 PM,"The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx",Benzinga,/news/stocks/the-daily-biotech-pulse-clinical-setback-for-adverum-galera-posts-data-readout-moderna-to-invest-in-vaccine-manufacturing-decision-day-for-ardelyx-1030364740,positive,0.7717582583427429
177,4/29/2021 8:10:08 PM,"ResMed EPS beats by $0.03, misses on revenue",Seeking Alpha,https://seekingalpha.com/news/3688155-resmed-eps-beats-0_03-misses-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.798983097076416
178,4/29/2021 10:05:00 PM,ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2021,GlobeNewswire,/news/stocks/resmed-inc-announces-results-for-the-third-quarter-of-fiscal-year-2021-1030366730,positive,0.8760018944740295
179,4/30/2021 4:31:04 AM,"ResMed Q1 Profit Tops View, But Revenues Miss ",RTTNews,/news/stocks/resmed-q1-profit-tops-view-but-revenues-miss-1030367510,neutral,0.5435066819190979
180,4/30/2021 5:08:39 PM,ResMed cut to neutral at Citi after earnings miss,Seeking Alpha,https://seekingalpha.com/news/3688797-resmed-cut-to-neutral-at-citi-after-earnings-miss?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6049041748046875
181,5/11/2021 4:07:20 PM,"Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-may-11-2021-1030415528,neutral,0.5851362347602844
182,5/11/2021 5:05:37 PM,ResMed goes ex-dividend tomorrow,Seeking Alpha,https://seekingalpha.com/news/3694712-resmed-goes-ex-dividend-tomorrow?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7853865027427673
183,5/21/2021 4:08:34 PM,"Benzinga's Top Ratings Upgrades, Downgrades For May 21, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-may-21-2021-1030455360,neutral,0.597612202167511
184,5/21/2021 5:14:07 PM,ResMed raised to overweight at J.P. Morgan citing product launch,Seeking Alpha,https://seekingalpha.com/news/3699201-resmed-raised-to-overweight-at-jp-morgan-citing-product-launch?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8676692247390747
185,5/25/2021 10:05:00 PM,ResMed Announces Participation in the William Blair 41st Annual Growth Stock Conference,GlobeNewswire,/news/stocks/resmed-announces-participation-in-the-william-blair-41st-annual-growth-stock-conference-1030464274,positive,0.8472104668617249
186,5/28/2021 7:30:56 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3701334-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8980498313903809
187,6/2/2021 3:00:00 PM,ResMed Announces Participation in the Goldman Sachs 42nd Annual Global Healthcare Conference,GlobeNewswire,/news/stocks/resmed-announces-participation-in-the-goldman-sachs-42nd-annual-global-healthcare-conference-1030487229,positive,0.7554318904876709
188,6/15/2021 10:56:05 AM,ResMed surges after product recall from Philips,Seeking Alpha,https://seekingalpha.com/news/3706298-resmed-surges-after-product-recall-from-philips?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9024217128753662
189,6/15/2021 2:07:38 PM,"The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda",Benzinga,/news/stocks/the-daily-biotech-pulse-astrazeneca-biogen-face-clinical-trial-disappointments-novavax-studies-coronavirus-flu-combo-vaccine-decision-day-for-takeda-1030523320,positive,0.9001525640487671
190,6/15/2021 4:10:47 PM,10 Biggest Price Target Changes For Tuesday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-tuesday-1030524490,positive,0.8152946829795837
191,6/16/2021 2:20:39 PM,"The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-regeneron-covid-19-antibody-cocktail-data-fda-nod-for-mallinckrodt-molecular-partners-ipo-1030527915,positive,0.9316365122795105
192,6/16/2021 2:57:56 PM,ResMed cut to neutral at BofA citing overreaction to rival’s product recall,Seeking Alpha,https://seekingalpha.com/news/3706941-resmed-cut-to-neutral-at-bofa-citing-overreaction-to-rivals-product-recall?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9474496245384216
193,6/16/2021 4:05:51 PM,"Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-june-16-2021-1030528698,neutral,0.5953537225723267
194,6/16/2021 7:16:48 PM,5 Reasons Why ResMed Gets Downgrade From BofA Securities,Benzinga,/news/stocks/5-reasons-why-resmed-gets-downgrade-from-bofa-securities-1030529496,positive,0.7850918173789978
195,6/21/2021 1:53:42 PM,10 Biggest Price Target Changes For Monday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-monday-1030538837,positive,0.7998325824737549
196,6/22/2021 4:02:46 PM,"Benzinga's Top Ratings Upgrades, Downgrades For June 22, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-june-22-2021-1030543448,neutral,0.586980938911438
197,6/22/2021 5:50:25 PM,Expert Ratings For ResMed,Benzinga,/news/stocks/expert-ratings-for-resmed-1030543948,positive,0.864109218120575
198,6/24/2021 2:12:04 PM,"The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-lilly-spikes-on-alzheimer-s-drug-regulatory-filing-plan-applied-genetics-arcus-issue-data-readouts-adcom-test-awaits-incyte-monte-rosa-prices-ipo-1030550889,positive,0.93064284324646
199,6/25/2021 1:32:32 PM,"The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-roche-gets-authorization-for-covid-19-treatment-nods-for-sanofi-regeneron-in-europe-osmotica-divestment-2-ipos-1030554577,negative,0.7482125759124756
200,6/30/2021 1:28:56 PM,"The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-covid-disappointments-for-altimmune-and-angion-brickell-jumps-on-hyperhidrosis-study-updates-2-ipos-1030566503,positive,0.7577856183052063
201,7/2/2021 1:38:37 PM,"The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures",Benzinga,/news/stocks/the-daily-biotech-pulse-iterum-s-regulatory-setback-decision-day-for-provention-bio-cidara-outset-medical-announce-cfo-departures-1030575170,neutral,0.8319647908210754
202,7/8/2021 1:45:17 PM,"The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test",Benzinga,/news/stocks/the-daily-biotech-pulse-priority-review-for-amgen-s-asthma-treatment-evaxion-reports-positive-skin-cancer-readout-quidel-recalls-lyra-covid-19-test-1030589266,positive,0.5796154737472534
203,7/14/2021 1:15:06 PM,"Roche upgraded on Alzheimer’s hopes, QIAGEN price target trimmed - today's analyst action",Seeking Alpha,https://seekingalpha.com/news/3715109-roche-upgraded-on-alzheimers-hopes-qiagen-price-target-trimmed-todays-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6451108455657959
204,7/14/2021 4:04:22 PM,"Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-july-14-2021-1030607185,neutral,0.5718769431114197
205,7/15/2021 10:05:00 PM,"ResMed to Report Fourth Quarter Fiscal 2021 Earnings on August 5, 2021",GlobeNewswire,/news/stocks/resmed-to-report-fourth-quarter-fiscal-2021-earnings-on-august-5-2021-1030613033,positive,0.9359733462333679
206,7/19/2021 9:06:09 PM,7 Growth Stocks to Buy As Meme Stock Mania Fades,InvestorPlace,/news/stocks/7-growth-stocks-to-buy-as-meme-stock-mania-fades-1030621979,positive,0.9204763770103455
207,7/22/2021 8:06:42 PM,Philips product recall classified by FDA as 'most serious' – Reuters,Seeking Alpha,https://seekingalpha.com/news/3718272-philips-product-recall-classified-by-fda-as-most-serious-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7766912579536438
208,7/23/2021 1:45:07 PM,"The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-acorda-spikes-on-distribution-deal-alzamend-soars-on-data-pfizer-biontech-to-supply-more-vaccine-doses-3-ipos-1030638740,negative,0.9013098478317261
209,7/27/2021 4:36:36 PM,Boston Scientific drives rival device makers higher after better-than-expected financials,Seeking Alpha,https://seekingalpha.com/news/3719838-boston-scientific-drives-rival-device-makers-higher-after-better-than-expected-financials?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8407343626022339
210,7/28/2021 1:45:40 PM,10 Biggest Price Target Changes For Wednesday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-wednesday-1030656023,positive,0.8142690658569336
211,7/28/2021 4:23:04 PM,"Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-july-28-2021-1030657262,neutral,0.593425989151001
212,7/29/2021 2:18:48 PM,"The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-merck-s-disappointing-q2-atreca-falls-on-data-fda-nod-for-viatris-nuvalent-icosavax-ipos-1030662210,neutral,0.9680227041244507
213,7/29/2021 6:03:44 PM,Expert Ratings For ResMed,Benzinga,/news/stocks/expert-ratings-for-resmed-1030663613,positive,0.864109218120575
214,7/30/2021 1:53:58 PM,"The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-erytech-jumps-on-fast-track-designation-glaxosmithkline-fda-nod-alnylam-s-clinical-collaboration-4-ipos-1030667906,negative,0.7937849164009094
215,8/2/2021 4:23:43 PM,"Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-august-2-2021-1030676997,neutral,0.5212735533714294
216,8/2/2021 4:57:22 PM,Needham downgrades ResMed to hold despite Philips Respironics woes,Seeking Alpha,https://seekingalpha.com/news/3723212-needham-downgrades-redmed-to-hold-despite-philips-respironics-woes?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8755553960800171
217,8/2/2021 7:20:40 PM,Where ResMed Stands With Analysts,Benzinga,/news/stocks/where-resmed-stands-with-analysts-1030677536,positive,0.9271209239959717
218,8/3/2021 3:02:13 PM,ResMed earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/resmed-stock-price-quarter-earnings-preview-q4-1030683675,positive,0.9339683651924133
219,8/4/2021 1:52:10 PM,"The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-s-positive-readout-nrx-strikes-r-d-collaboration-with-mannkind-cerus-invitae-jump-on-earnings-1030688766,negative,0.7550449371337891
220,8/4/2021 9:35:49 PM,Notable earnings after Thursday's close,Seeking Alpha,https://seekingalpha.com/news/3724969-notable-earnings-after-thursdays-close?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8900269269943237
221,8/5/2021 2:07:56 PM,"The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO",Benzinga,/news/stocks/the-daily-biotech-pulse-merck-reports-positive-keytruda-readout-moderna-slips-despite-q2-beat-bayer-to-buy-vividion-for-up-to-2b-glycomimetics-gets-new-ceo-1030695873,negative,0.8679100871086121
222,8/5/2021 8:34:08 PM,"ResMed EPS beats by $0.06, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3726509-resmed-eps-beats-by-006-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8625127077102661
223,8/5/2021 10:05:00 PM,ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2021,GlobeNewswire,/news/stocks/resmed-inc-announces-results-for-the-fourth-quarter-of-fiscal-year-2021-1030697777,positive,0.868232786655426
224,8/5/2021 10:47:36 PM,Resmed Inc Q4 adjusted earnings Beat Estimates,RTTNews,/news/stocks/resmed-inc-q4-adjusted-earnings-beat-estimates-1030698284,negative,0.8866145610809326
225,8/16/2021 3:00:00 PM,"ResMed Launches AirSense 11 PAP Series, Advancing Digital Health in Sleep Apnea Treatment",GlobeNewswire,/news/stocks/resmed-launches-airsense-11-pap-series-advancing-digital-health-in-sleep-apnea-treatment-1030734458,positive,0.5223925709724426
226,8/17/2021 2:28:53 PM,"The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business",Benzinga,/news/stocks/the-daily-biotech-pulse-lilly-reorganizes-business-units-in-neuroscience-focus-helius-medical-spikes-on-breakthrough-designation-ra-medical-sells-dermatology-business-1030738023,positive,0.9126444458961487
227,8/18/2021 1:37:56 PM,"The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline",Benzinga,/news/stocks/the-daily-biotech-pulse-azurrx-jumps-on-data-agios-regulatory-application-for-mitapivat-accepted-for-priority-review-fda-nod-for-glaxosmithkline-1030741574,negative,0.5053824782371521
228,8/19/2021 1:37:27 PM,"The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck",Benzinga,/news/stocks/the-daily-biotech-pulse-coherus-soars-on-lung-cancer-data-illumina-closes-on-grail-buy-without-regulatory-clearance-adagene-strikes-collaboration-with-merck-1030745371,neutral,0.7770193219184875
229,8/20/2021 1:45:43 PM,"The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data",Benzinga,/news/stocks/the-daily-biotech-pulse-j-j-announces-ceo-transition-fibrogen-s-roxadustat-approved-in-europe-geovax-sorrento-announce-covid-19-vaccine-data-1030748705,positive,0.8679837584495544
230,8/24/2021 2:09:21 PM,"The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal",Benzinga,/news/stocks/the-daily-biotech-pulse-cara-s-korsuva-greenlighted-by-fda-clinical-trial-disappointments-for-novartis-theravance-vertex-inks-crispr-licensing-deal-1030754775,positive,0.5257502198219299
231,8/25/2021 10:15:00 PM,ResMed Announces SaaS Leadership Change,GlobeNewswire,/news/stocks/resmed-announces-saas-leadership-change-1030758917,positive,0.9119831323623657
232,8/31/2021 2:06:37 PM,"The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical",Benzinga,/news/stocks/the-daily-biotech-pulse-vectivbio-in-m-a-mix-sonnet-biotherapeutics-advances-candidate-to-clinics-ceo-transitions-at-galapagos-talis-biomedical-1030769575,positive,0.8613703846931458
233,9/2/2021 3:00:00 PM,ResMed Announces Participation in the Morgan Stanley 19th Annual Global Healthcare Conference,GlobeNewswire,/news/stocks/resmed-announces-participation-in-the-morgan-stanley-19th-annual-global-healthcare-conference-1030776613,positive,0.7085395455360413
234,9/3/2021 7:00:00 PM,"Catalyst watch for next week: GameStop and Affirm earnings, Coupang lock-up expiration, eyes on WKHS, SPRT, SYF",Seeking Alpha,https://seekingalpha.com/news/3735835-catalyst-watch-for-next-week-gamestop-and-affirm-earning-coupang-lock-up-expiration?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.870329737663269
235,9/8/2021 12:45:00 PM,"People with Sleep Apnea Live Longer on CPAP in Large, Late-Breaking ResMed-Supported ALASKA Study Presented at ERS",GlobeNewswire,/news/stocks/people-with-sleep-apnea-live-longer-on-cpap-in-large-late-breaking-resmed-supported-alaska-study-presented-at-ers-1030786551,negative,0.481260746717453
236,9/8/2021 1:32:08 PM,"The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod",Benzinga,/news/stocks/the-daily-biotech-pulse-macrogenics-clinical-trial-disappointment-sanofi-to-buy-kadmon-alector-loses-2-key-executives-adma-s-fda-nod-1030786678,positive,0.5691104531288147
237,9/8/2021 1:43:21 PM,Philips is a buy after recent weakness; Siemens Healthineers a long-term hold - Jefferies,Seeking Alpha,https://seekingalpha.com/news/3737939-philips-is-a-buy-after-recent-weakness-siemens-healthineers-a-long-term-hold-jefferies?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6729715466499329
238,9/8/2021 3:00:00 PM,ResMed Announces Participation in the Bank of America Global Healthcare Conference,GlobeNewswire,/news/stocks/resmed-announces-participation-in-the-bank-of-america-global-healthcare-conference-1030787222,positive,0.7125860452651978
239,9/9/2021 2:17:07 PM,"The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization",Benzinga,/news/stocks/the-daily-biotech-pulse-proqr-lilly-r-d-partnership-sanofi-s-pemphigus-trial-disappointment-humanigen-s-covid-19-drug-denied-emergency-use-authorization-1030789942,positive,0.9088907241821289
240,9/10/2021 2:00:05 PM,"The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test",Benzinga,/news/stocks/the-daily-biotech-pulse-apellis-sinks-on-data-endo-shines-on-opioid-litigation-settlement-t2-biosystems-soars-on-mutant-detection-ability-of-covid-test-1030792468,neutral,0.43603116273880005
241,10/7/2021 10:05:00 PM,"ResMed to Report First Quarter Fiscal 2022 Earnings on October 28, 2021",GlobeNewswire,/news/stocks/resmed-to-report-first-quarter-fiscal-2022-earnings-on-october-28-2021-1030851529,positive,0.9441235661506653
242,10/24/2021 5:45:47 PM,"The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-oct-24-30-eyenovia-ani-pharma-clearside-medical-fda-decisions-merck-bristol-myers-squibb-earnings-ipos-and-more-1030891741,positive,0.9414970874786377
243,10/26/2021 3:02:03 PM,ResMed earnings preview: what Wall Street is expecting,Markets Insider Automation,/news/stocks/resmed-stock-price-quarter-earnings-preview-q1-1030899698,positive,0.9105846285820007
244,10/27/2021 11:27:29 AM,BofA screens best and worst stocks for rising Treasury yields: At the Open,Seeking Alpha,https://seekingalpha.com/news/3758799-bofa-screens-top-stocks-for-rising-and-falling-treasury-yields?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7531453371047974
245,10/27/2021 9:35:07 PM,Notable earnings after Thursday's close,Seeking Alpha,https://seekingalpha.com/news/3759032-notable-earnings-after-thursdays-close?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8900269269943237
246,10/27/2021 9:35:55 PM,ResMed FQ1 2022 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3759251-resmed-fq1-2022-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.836993396282196
247,10/28/2021 2:26:10 PM,"The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug",Benzinga,/news/stocks/the-daily-biotech-pulse-merck-reports-beat-and-raise-quarter-pfizer-biontech-snag-orders-for-additional-vaccine-doses-hcw-cleared-for-phase-1-study-of-pancreatic-cancer-drug-1030910260,negative,0.8363469839096069
248,10/28/2021 8:07:09 PM,"ResMed EPS beats by $0.16, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3760326-resmed-eps-beats-0_16-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8147334456443787
249,10/28/2021 9:23:25 PM,ResMed posts FQ1 earnings beat on sleep and respiratory care products strength,Seeking Alpha,https://seekingalpha.com/news/3760553-resmed-posts-fq1-earnings-beat-on-sleep-and-respiratory-care-products-strength?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8840155005455017
250,10/28/2021 9:56:54 PM,ResMed declares $0.42 dividend,Seeking Alpha,https://seekingalpha.com/news/3760574-resmed-declares-042-dividend?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9421147704124451
251,10/28/2021 10:05:00 PM,ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2022,GlobeNewswire,/news/stocks/resmed-inc-announces-results-for-the-first-quarter-of-fiscal-year-2022-1030911922,positive,0.9182059168815613
252,10/28/2021 11:04:37 PM,Resmed Inc Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/resmed-inc-q1-adjusted-earnings-beat-estimates-1030912348,negative,0.8655866384506226
253,11/3/2021 2:00:00 PM,ResMed Announces Participation in the Credit Suisse 30th Annual Healthcare Conference,GlobeNewswire,/news/stocks/resmed-announces-participation-in-the-credit-suisse-30th-annual-healthcare-conference-1030932034,positive,0.7807101011276245
254,11/15/2021 12:11:43 PM,ResMed gains as competitor faces more troubles in ventilator recall,Seeking Alpha,https://seekingalpha.com/news/3770475-resmed-gains-as-competitor-faces-more-troubles-in-ventilator-recall?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8346150517463684
255,11/16/2021 2:24:19 PM,Philips granted FDA clearance for tools to measure liver fat,Seeking Alpha,https://seekingalpha.com/news/3771429-philips-granted-fda-clearance-for-tools-to-measure-liver-fat?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8195830583572388
256,11/19/2021 3:00:00 PM,ResMed Elects Health Tech Leaders Desney Tan and John Hernandez to Its Board of Directors,GlobeNewswire,/news/stocks/resmed-elects-health-tech-leaders-desney-tan-and-john-hernandez-to-its-board-of-directors-1030991585,positive,0.9287402629852295
257,12/6/2021 4:05:46 PM,"Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-december-6-2021-1031026544,neutral,0.5734043121337891
258,12/21/2021 4:13:27 PM,"Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-december-21-2021-1031059567,neutral,0.6060469150543213
259,12/21/2021 8:41:10 PM,ResMed upgraded at KeyBanc citing current competitive backdrop,Seeking Alpha,https://seekingalpha.com/news/3782484-resmed-upgraded-at-keybanc-citing-current-competitive-backdrop?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8045703172683716
260,12/30/2021 3:00:00 PM,ResMed Announces Participation in the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference,GlobeNewswire,/news/stocks/resmed-announces-participation-in-the-goldman-sachs-14th-annual-healthcare-ceos-unscripted-conference-1031084264,positive,0.8111865520477295
261,1/3/2022 3:00:00 PM,ResMed Announces Participation in the 40th Annual J.P. Morgan Healthcare Conference,GlobeNewswire,/news/stocks/resmed-announces-participation-in-the-40th-annual-j-p-morgan-healthcare-conference-1031085870,negative,0.6219595074653625
262,1/6/2022 10:05:00 PM,"ResMed to Report Second Quarter Fiscal 2022 Earnings on January 27, 2022",GlobeNewswire,/news/stocks/resmed-to-report-second-quarter-fiscal-2022-earnings-on-january-27-2022-1031087084,positive,0.939736545085907
263,1/13/2022 4:06:15 PM,"Benzinga's Top Ratings Upgrades, Downgrades For January 13, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-january-13-2022-1031100637,neutral,0.5175359845161438
264,1/13/2022 6:02:07 PM,What 4 Analyst Ratings Have To Say About ResMed,Benzinga,/news/stocks/what-4-analyst-ratings-have-to-say-about-resmed-1031101042,positive,0.9454975128173828
265,1/13/2022 7:24:25 PM,"ResMed gets upgrade at Baird, CLSA amid Philips' woes",Seeking Alpha,https://seekingalpha.com/news/3788038-resmed-gets-upgrade-at-baird-clsa-amid-philips-woes?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.941448450088501
266,1/24/2022 4:04:07 PM,"Benzinga's Top Ratings Upgrades, Downgrades For January 24, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-january-24-2022-1031123092,neutral,0.5323784351348877
267,1/24/2022 7:56:51 PM,ResMed defies selloff after upgrades from JPMorgan and BofA,Seeking Alpha,https://seekingalpha.com/news/3790919-resmed-defies-selloff-after-upgrades-from-jpmorgan-and-bofa?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5682960152626038
268,1/26/2022 3:01:13 PM,What Wall Street expects from ResMed's earnings,Markets Insider Automation,/news/stocks/resmed-quarter-earnings-preview-q2-1031130936,positive,0.9305833578109741
269,1/26/2022 10:35:30 PM,Notable earnings after Thursday's close,Seeking Alpha,https://seekingalpha.com/news/3791847-notable-earnings-after-thursdays-close?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8900269269943237
270,1/27/2022 1:57:50 PM,"The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study",Benzinga,/news/stocks/the-daily-biotech-pulse-galapagos-appoints-j-j-exec-as-ceo-aridis-gets-funding-for-antiviral-treatment-moderna-starts-omicron-specific-booster-study-1031135162,positive,0.7180495262145996
271,1/27/2022 9:09:14 PM,"ResMed Non-GAAP EPS of $1.47 misses by $0.05, revenue of $894.9M misses by $32.59M",Seeking Alpha,https://seekingalpha.com/news/3792709-resmed-non-gaap-eps-of-1_47-misses-0_05-revenue-of-894_9m-misses-32_59m?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7796611189842224
272,1/27/2022 10:05:00 PM,ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2022,GlobeNewswire,/news/stocks/resmed-inc-announces-results-for-the-second-quarter-of-fiscal-year-2022-1031137038,positive,0.9163578152656555
273,1/27/2022 10:08:40 PM,ResMed down ~7% after hours on top and bottom line quarterly misses,Seeking Alpha,https://seekingalpha.com/news/3792831-resmed-down-7-after-hours-on-top-and-bottom-line-quarterly-misses?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9741479158401489
274,1/27/2022 10:34:35 PM,Resmed Inc Q2 Profit Misses Estimates,RTTNews,/news/stocks/resmed-inc-q2-profit-misses-estimates-1031137197,neutral,0.9025209546089172
275,1/28/2022 2:21:16 PM,"The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron",Benzinga,/news/stocks/the-daily-biotech-pulse-biogen-liquidates-out-of-biosimilar-jv-provention-bio-plots-diabetes-drug-resubmission-merck-finds-covid-pill-effective-against-omicron-1031139273,negative,0.8550984263420105
276,1/28/2022 4:17:35 PM,"Benzinga's Top Ratings Upgrades, Downgrades For January 28, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-january-28-2022-1031139751,neutral,0.555918276309967
277,1/28/2022 5:13:16 PM,ResMed upgraded to market perform at RBC following quarterly results; shares down 6%,Seeking Alpha,https://seekingalpha.com/news/3793165-resmed-upgraded-to-market-perform-at-rbc-following-quarterly-results?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9532349705696106
278,1/31/2022 8:26:20 PM,Expert Ratings For ResMed,Benzinga,/news/stocks/expert-ratings-for-resmed-1031145758,positive,0.864109218120575
279,2/1/2022 2:22:45 PM,ResMed names new CTO,Seeking Alpha,https://seekingalpha.com/news/3794063-resmed-names-new-cto?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9163466095924377
280,2/1/2022 3:00:00 PM,ResMed Welcomes Urvashi Tyagi as New Chief Technology Officer,GlobeNewswire,/news/stocks/resmed-welcomes-urvashi-tyagi-as-new-chief-technology-officer-1031149394,positive,0.8312232494354248
281,2/8/2022 5:11:45 PM,ResMed declares go ex dividend tomorrow,Seeking Alpha,https://seekingalpha.com/news/3797373-resmed-inc-declares-missing-dividend?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9117356538772583
282,2/16/2022 3:00:00 PM,ResMed Announces Participation in the Citi Healthcare Conference,GlobeNewswire,/news/stocks/resmed-announces-participation-in-the-citi-healthcare-conference-1031200978,positive,0.8026598691940308
283,2/25/2022 8:48:40 PM,3 Beaten-Down Growth Stocks With More Than 50% Upside Potential,InvestorPlace,/news/stocks/3-beaten-down-growth-stocks-with-more-than-50-upside-potential-1031233353,neutral,0.9221370816230774
284,3/10/2022 3:00:10 PM,ResMed Announces Participation in the Oppenheimer 32nd Annual Healthcare Conference,GlobeNewswire,/news/stocks/resmed-announces-participation-in-the-oppenheimer-32nd-annual-healthcare-conference-1031270407,positive,0.8421481847763062
285,3/14/2022 2:00:00 PM,ResMed’s Global Sleep Surveys Reveal What’s Keeping Us Up at Night; Aim to Bring Awareness to the State of Sleep Health for World Sleep Day,GlobeNewswire,/news/stocks/resmed-s-global-sleep-surveys-reveal-what-s-keeping-us-up-at-night-aim-to-bring-awareness-to-the-state-of-sleep-health-for-world-sleep-day-1031277907,positive,0.7169216275215149
286,3/17/2022 9:05:00 PM,ResMed Announces Participation in the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum,GlobeNewswire,/news/stocks/resmed-announces-participation-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum-1031289931,positive,0.7620620131492615
287,3/23/2022 3:23:57 PM,ResMed posts biggest intraday loss in nearly 11 months on supply issues,Seeking Alpha,https://seekingalpha.com/news/3816518-resmed-posts-biggest-intraday-loss-in-nearly-11-months-on-supply-issues?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9710310101509094
288,3/23/2022 4:17:58 PM,Medical equipment makers drag healthcare sector,Seeking Alpha,https://seekingalpha.com/news/3816537-medical-equipment-makers-drag-healthcare-sector?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7234996557235718
289,4/6/2022 4:16:32 PM,"Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-april-6-2022-1031337076,positive,0.5202335715293884
290,4/6/2022 7:09:02 PM,What 5 Analyst Ratings Have To Say About ResMed,Benzinga,/news/stocks/what-5-analyst-ratings-have-to-say-about-resmed-1031337650,positive,0.9458091259002686
291,4/7/2022 10:05:00 PM,"ResMed to Report Third Quarter Fiscal 2022 Earnings on April 28, 2022",GlobeNewswire,/news/stocks/resmed-to-report-third-quarter-fiscal-2022-earnings-on-april-28-2022-1031341256,positive,0.9410799741744995
292,4/27/2022 3:01:13 PM,ResMed earnings preview: what to expect,Markets Insider Automation,/news/stocks/resmed-q3-quarterly-earnings-preview-1031391404,positive,0.9064379334449768
293,4/27/2022 9:35:10 PM,Notable earnings after Thursday's close,Seeking Alpha,https://seekingalpha.com/news/3827653-notable-earnings-after-thursdays-close?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8900269269943237
294,4/27/2022 9:45:08 PM,ResMed Q3 2022 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3827706-resmed-q3-2022-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9005613923072815
295,4/27/2022 10:05:00 PM,ResMed Announces Participation in the 24th Annual Macquarie Australia Conference,GlobeNewswire,/news/stocks/resmed-announces-participation-in-the-24th-annual-macquarie-australia-conference-1031392902,positive,0.7523412108421326
296,4/28/2022 8:11:12 PM,"ResMed Non-GAAP EPS of $1.32 misses by $0.12, revenue of $864.5M misses by $35.53M",Seeking Alpha,https://seekingalpha.com/news/3828877-resmed-non-gaap-eps-of-1_32-misses-0_12-revenue-of-864_5m-misses-35_53m?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7925605177879333
297,4/28/2022 10:05:00 PM,ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2022,GlobeNewswire,/news/stocks/resmed-inc-announces-results-for-the-third-quarter-of-fiscal-year-2022-1031398937,positive,0.9154224395751953
298,4/28/2022 11:26:11 PM,Resmed Inc Q3 Earnings Summary,RTTNews,/news/stocks/resmed-inc-q3-earnings-summary-1031399411,positive,0.5818251371383667
299,4/30/2022 12:23:04 AM,What 3 Analyst Ratings Have To Say About ResMed,Benzinga,/news/stocks/what-3-analyst-ratings-have-to-say-about-resmed-1031403790,positive,0.9451580047607422
300,5/4/2022 10:39:59 AM,"Starbucks, Meta, Exxon among many stocks dropping off BofA's Alpha Surprise screen",Seeking Alpha,https://seekingalpha.com/news/3831217-starbucks-meta-exxon-among-many-stocks-dropping-off-bofas-alpa-surprise-screen?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.948421835899353
301,5/5/2022 10:05:00 PM,ResMed Announces Leadership Change,GlobeNewswire,/news/stocks/resmed-announces-leadership-change-1031427444,positive,0.8960756659507751
302,5/10/2022 6:16:53 PM,ResMed goes ex-dividend tomorrow,Seeking Alpha,https://seekingalpha.com/news/3836157-resmed-inc-declares-missing-dividend?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7853865027427673
303,5/18/2022 10:05:00 PM,Even 2 Hours of PAP Therapy per Night Benefits Sleep Apnea Sufferers: ResMed Study,GlobeNewswire,/news/stocks/even-2-hours-of-pap-therapy-per-night-benefits-sleep-apnea-sufferers-resmed-study-1031473565,positive,0.7452659606933594
304,5/25/2022 3:00:00 PM,ResMed Announces Participation in the 38th Annual Bernstein Strategic Decisions Conference,GlobeNewswire,/news/stocks/resmed-announces-participation-in-the-38th-annual-bernstein-strategic-decisions-conference-1031488388,positive,0.8516508936882019
305,6/1/2022 3:00:00 PM,ResMed Announces Participation in the 42nd Annual William Blair Growth Stock Conference,GlobeNewswire,/news/stocks/resmed-announces-participation-in-the-42nd-annual-william-blair-growth-stock-conference-1031501925,positive,0.8442850112915039
306,6/3/2022 11:10:52 AM,"Amazon, Domino's among additions to BofA's Alpha Surprise screen",Seeking Alpha,https://seekingalpha.com/news/3845109-amazon-dominos-among-additions-to-bofas-alpha-surprise-screen?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6103911399841309
307,6/6/2022 1:45:47 PM,10 Biggest Price Target Changes For Monday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-monday-1031510659,positive,0.7998325824737549
308,6/6/2022 5:12:03 PM,"Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-june-6-2022-1031511325,positive,0.5026875734329224
309,6/6/2022 5:22:10 PM,Analyst Ratings for ResMed,Benzinga,/news/stocks/analyst-ratings-for-resmed-1031511344,positive,0.9134358167648315
310,6/7/2022 3:00:00 PM,ResMed Announces Participation in the 43rd Annual Goldman Sachs Global Healthcare Conference,GlobeNewswire,/news/stocks/resmed-announces-participation-in-the-43rd-annual-goldman-sachs-global-healthcare-conference-1031513563,positive,0.7901214957237244
311,6/14/2022 12:02:45 AM,ResMed nears $1B deal to buy health software provider MediFox - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3848252-resmed-nears-1b-deal-to-buy-health-software-provider-medifox-bloomberg?utm_source=businessinsider&utm_medium=referral,negative,0.6660919189453125
312,6/14/2022 8:05:00 AM,"ResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software Solutions",GlobeNewswire,/news/stocks/resmed-to-acquire-medifox-dan-a-german-leader-in-out-of-hospital-software-solutions-1031526699,positive,0.579538106918335
313,6/14/2022 9:22:34 AM,ResMed to acquire German health software company MediFox for ~$1B,Seeking Alpha,https://seekingalpha.com/news/3848294-resmed-to-acquire-german-health-software-company-medifox-for-1b?utm_source=businessinsider&utm_medium=referral,positive,0.8679719567298889
314,6/28/2022 3:00:00 PM,"ResMed Promotes Lucile Blaise to President, Sleep & Respiratory Care",GlobeNewswire,/news/stocks/resmed-promotes-lucile-blaise-to-president-sleep-respiratory-care-1031554661,positive,0.8392747044563293
315,7/14/2022 10:05:00 PM,"ResMed to Report Fourth Quarter Fiscal 2022 Earnings on August 11, 2022",GlobeNewswire,/news/stocks/resmed-to-report-fourth-quarter-fiscal-2022-earnings-on-august-11-2022-1031588757,positive,0.940297544002533
316,7/22/2022 8:15:08 PM,Semiconductor Shortages - See How ResMed Is Tackling,Benzinga,/news/stocks/semiconductor-shortages---see-how-resmed-is-tackling-1031608422,positive,0.8853083252906799
317,7/25/2022 12:57:37 PM,Mehul Joshi joins Berkeley Lights as CFO,Seeking Alpha,https://seekingalpha.com/news/3859979-mehul-joshi-joins-berkeley-lights-as-cfo?utm_source=businessinsider&utm_medium=referral,positive,0.9429185390472412
318,8/2/2022 9:35:04 AM,ResMed acquires digital insomnia therapy company mementor to bolster sleep  portfolio,Seeking Alpha,https://seekingalpha.com/news/3864429-resmed-acquires-digital-insomnia-therapy-company-mementor-to-bolster-sleep-portfolio?utm_source=businessinsider&utm_medium=referral,negative,0.8689051866531372
319,8/2/2022 11:00:00 AM,ResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnio,GlobeNewswire,/news/stocks/resmed-acquires-leipzig-based-mementor-with-insomnia-digital-health-solution-somnio-1031638791,positive,0.7986508011817932
320,8/10/2022 3:01:13 PM,ResMed is about to announce its earnings — here's what to expect,Markets Insider Automation,/news/stocks/resmed-q4-quarterly-earnings-preview-stock-1031670823,positive,0.9416394233703613
321,8/10/2022 9:35:47 PM,ResMed Q4 2022 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3870811-resmed-q4-2022-earnings-preview?utm_source=businessinsider&utm_medium=referral,positive,0.9012905955314636
322,8/10/2022 9:35:52 PM,Notable earnings after Thursday's close,Seeking Alpha,https://seekingalpha.com/news/3870724-notable-earnings-after-thursdays-close?utm_source=businessinsider&utm_medium=referral,negative,0.8900269269943237
323,8/11/2022 8:10:27 PM,"ResMed Non-GAAP EPS of $1.49 beats by $0.03, revenue of $914.74M beats by $2.22M",Seeking Alpha,https://seekingalpha.com/news/3871821-resmed-non-gaap-eps-of-1_49-beats-0_03-revenue-of-914_74m-beats-2_22m?utm_source=businessinsider&utm_medium=referral,positive,0.6695613265037537
324,8/11/2022 10:05:00 PM,ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2022,GlobeNewswire,/news/stocks/resmed-inc-announces-results-for-the-fourth-quarter-of-fiscal-year-2022-1031677153,positive,0.9124789834022522
325,8/11/2022 10:48:16 PM,Resmed Inc Q4 sales increase,RTTNews,/news/stocks/resmed-inc-q4-sales-increase-1031677456,negative,0.900741457939148
326,8/12/2022 10:34:30 AM,ResMed raises dividend by ~5% to $0.44/share,Seeking Alpha,https://seekingalpha.com/news/3872216-resmed-raises-dividend-by-5-to-044share?utm_source=businessinsider&utm_medium=referral,negative,0.9232304692268372
327,8/12/2022 4:14:51 PM,"Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-august-12-2022-1031680160,positive,0.5128582715988159
328,8/12/2022 4:27:52 PM,ResMed downgraded at JPMorgan and RBC despite earnings beat,Seeking Alpha,https://seekingalpha.com/news/3872431-rmd-stock-downgraded-at-jpmorgan-and-rbc-despite-earnings-beat?utm_source=businessinsider&utm_medium=referral,neutral,0.9445479512214661
329,8/13/2022 12:34:11 AM,Competitor Recall Continues To Show Opportunities For ResMed,Benzinga,/news/stocks/competitor-recall-continues-to-show-opportunities-for-resmed-1031680882,negative,0.9373912215232849
330,9/4/2022 2:00:00 PM,"Over 480 Million People Estimated to Have COPD, World’s Third Deadliest Disease, ResMed Study Reports",GlobeNewswire,/news/stocks/over-480-million-people-estimated-to-have-copd-world-s-third-deadliest-disease-resmed-study-reports-1031723290,positive,0.7033248543739319
331,9/6/2022 3:00:00 PM,ResMed Announces Participation in the 20th Annual Morgan Stanley Global Healthcare Conference,GlobeNewswire,/news/stocks/resmed-announces-participation-in-the-20th-annual-morgan-stanley-global-healthcare-conference-1031726381,positive,0.6702389121055603
332,9/7/2022 3:00:00 PM,ResMed Announces Participation in the Bank of America Global Healthcare Conference,GlobeNewswire,/news/stocks/resmed-announces-participation-in-the-bank-of-america-global-healthcare-conference-1031729308,positive,0.7125860452651978
333,10/12/2022 4:02:53 PM,"Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-october-12-2022-1031799955,positive,0.5273875594139099
334,10/13/2022 10:05:00 PM,"ResMed to Report First Quarter Fiscal 2023 Earnings on October 27, 2022",GlobeNewswire,/news/stocks/resmed-to-report-first-quarter-fiscal-2023-earnings-on-october-27-2022-1031804409,positive,0.9458299279212952
335,10/20/2022 2:07:41 PM,ResMed raised to Buy at BofA citing Q1 beat,Seeking Alpha,https://seekingalpha.com/news/3893223-rmd-stock-raised-to-buy-at-bofa-citing-q1-beat?utm_source=businessinsider&utm_medium=referral,positive,0.5025821924209595
336,10/20/2022 4:03:57 PM,"Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-october-20-2022-1031821613,positive,0.5239018797874451
337,10/26/2022 3:01:13 PM,Here's what Wall Street expects from ResMed's earnings,Markets Insider Automation,/news/stocks/resmed-q1-quarterly-earnings-preview-stock-1031838068,positive,0.932039201259613
338,10/26/2022 9:35:42 PM,ResMed Q1 2023 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3895599-resmed-q1-2023-earnings-preview?utm_source=businessinsider&utm_medium=referral,positive,0.9066399335861206
339,10/27/2022 8:17:10 PM,"ResMed Non-GAAP EPS of $1.51 misses by $0.09, revenue of $950.3M beats by $4.39M",Seeking Alpha,https://seekingalpha.com/news/3896823-resmed-non-gaap-eps-of-1_51-misses-0_09-revenue-of-950_3m-beats-4_39m?utm_source=businessinsider&utm_medium=referral,positive,0.7658635973930359
340,10/27/2022 9:03:01 PM,ResMed declares $0.44 dividend,Seeking Alpha,https://seekingalpha.com/news/3896934-resmed-declares-044-dividend?utm_source=businessinsider&utm_medium=referral,positive,0.9427249431610107
341,10/27/2022 10:05:00 PM,ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2023,GlobeNewswire,/news/stocks/resmed-inc-announces-results-for-the-first-quarter-of-fiscal-year-2023-1031845080,positive,0.9177756309509277
342,10/28/2022 12:03:53 AM,"Resmed Inc Q1 Profit Increases, but misses estimates",RTTNews,/news/stocks/resmed-inc-q1-profit-increases-but-misses-estimates-1031845581,negative,0.8884100317955017
343,10/28/2022 9:35:08 AM,Needham Reaffirms Their Hold Rating on Resmed (RMD),TipRanks,/news/stocks/needham-reaffirms-their-hold-rating-on-resmed-rmd-1031847673,positive,0.7941057085990906
344,10/28/2022 3:05:30 PM,Where ResMed Stands With Analysts,Benzinga,/news/stocks/where-resmed-stands-with-analysts-1031848493,positive,0.9271209239959717
345,10/28/2022 7:10:35 PM,ResMed shares fall 6% despite reporting FQ1 2023 revenue growth,Seeking Alpha,https://seekingalpha.com/news/3897449-resmed-shares-fall-6-despite-reporting-fq1-2023-revenue-growth?utm_source=businessinsider&utm_medium=referral,neutral,0.9710736274719238
346,10/31/2022 12:12:46 PM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Insulet (PODD), Resmed (RMD) and Merck & Company (MRK)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-insulet-podd-resmed-rmd-and-merck-company-mrk-1031853390,neutral,0.8243153691291809
347,11/22/2022 3:00:30 PM,"ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions",GlobeNewswire,/news/stocks/resmed-completes-acquisition-of-medifox-dan-a-german-leader-in-out-of-hospital-care-management-software-solutions-1031931393,negative,0.5829757452011108
348,12/5/2022 10:45:14 AM,Needham Reaffirms Their Hold Rating on Resmed (RMD),TipRanks,/news/stocks/needham-reaffirms-their-hold-rating-on-resmed-rmd-1031952892,positive,0.7941057085990906
349,1/17/2023 4:01:25 PM,"Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-january-17-2023-1032022889,neutral,0.5494208931922913
350,1/19/2023 10:25:11 AM,Needham Sticks to Its Hold Rating for Resmed (RMD),TipRanks,/news/stocks/needham-sticks-to-its-hold-rating-for-resmed-rmd-1032027850,positive,0.8676764965057373
351,1/25/2023 3:01:13 PM,Here's what to expect from ResMed's earnings,Markets Insider Automation,/news/stocks/resmed-q2-earnings-preview-1032040491,positive,0.9401078820228577
352,1/25/2023 10:35:02 PM,ResMed Q2 2023 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3927915-resmed-q2-2023-earnings-preview?utm_source=businessinsider&utm_medium=referral,positive,0.9018495678901672
353,1/25/2023 10:35:10 PM,Notable earnings after Thursday's close,Seeking Alpha,https://seekingalpha.com/news/3927792-notable-earnings-after-thursdays-close?utm_source=businessinsider&utm_medium=referral,negative,0.8900269269943237
354,1/26/2023 1:45:29 AM,Resmed (RMD) Gets a Hold from RBC Capital,TipRanks,/news/stocks/resmed-rmd-gets-a-hold-from-rbc-capital-1032042052,positive,0.8601844906806946
355,1/26/2023 9:10:31 PM,"ResMed Non-GAAP EPS of $1.66 beats by $0.04, revenue of $1.03B beats by $33.78M",Seeking Alpha,https://seekingalpha.com/news/3928657-resmed-non-gaap-eps-of-1_66-beats-0_04-revenue-of-1_03b-beats-33_78m?utm_source=businessinsider&utm_medium=referral,positive,0.7693104147911072
356,1/26/2023 9:52:48 PM,ResMed appoints CEO Michael Farrell as chair of the board,Seeking Alpha,https://seekingalpha.com/news/3928741-resmed-appoints-ceo-michael-farrell-as-chair-of-the-board?utm_source=businessinsider&utm_medium=referral,positive,0.9147512912750244
357,1/26/2023 10:15:18 PM,"Resmed Inc Q2 Profit Increases, beats estimates",RTTNews,/news/stocks/resmed-inc-q2-profit-increases-beats-estimates-1032044994,negative,0.9347113370895386
358,1/27/2023 10:55:11 AM,Resmed (RMD) Receives a Hold from Needham,TipRanks,/news/stocks/resmed-rmd-receives-a-hold-from-needham-1032046328,positive,0.8823018074035645
359,1/30/2023 8:50:17 AM,"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Resmed (RMD) and Sarepta Therapeutics (SRPT)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-amgen-amgn-resmed-rmd-and-sarepta-therapeutics-srpt-1032050147,positive,0.912641167640686
360,1/30/2023 10:05:19 AM,Bank of America Securities Remains a Buy on Resmed (RMD),TipRanks,/news/stocks/bank-of-america-securities-remains-a-buy-on-resmed-rmd-1032050306,positive,0.9475389719009399
361,1/31/2023 1:51:54 AM,Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and PTC Therapeutics (PTCT),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-resmed-rmd-and-ptc-therapeutics-ptct-1032052159,positive,0.9094907641410828
362,2/2/2023 6:12:11 PM,"Merck, GM among BofA's latest Alpha Surprise picks",Seeking Alpha,https://seekingalpha.com/news/3931429-merck-gm-among-bofas-latest-alpha-surprise-picks?utm_source=businessinsider&utm_medium=referral,positive,0.8229635953903198
363,2/7/2023 6:35:22 PM,ResMed goes ex dividend tomorrow,Seeking Alpha,https://seekingalpha.com/news/3933056-resmed-inc-declares-missing-dividend?utm_source=businessinsider&utm_medium=referral,positive,0.8890487551689148
364,2/25/2023 9:00:00 PM,"Pharmas, medtechs dominate list of innovation leaders thanks to patents",Seeking Alpha,https://seekingalpha.com/news/3940793-pharmas-medtechs-dominate-list-of-innovation-leaders-thanks-to-patents?utm_source=businessinsider&utm_medium=referral,positive,0.6739813089370728
365,3/2/2023 5:35:01 PM,Stocks that thrive and struggle the most as rates rise - BofA,Seeking Alpha,https://seekingalpha.com/news/3943181-stocks-helped-and-hit-hard-by-rising-rates?utm_source=businessinsider&utm_medium=referral,positive,0.5202491283416748
366,4/14/2023 4:00:45 PM,Philips clarifies on respiratory device recall after FDA warning,Seeking Alpha,https://seekingalpha.com/news/3956649-philips-stock-clarifies-respiratory-device-recall-after-fda-warning?utm_source=businessinsider&utm_medium=referral,positive,0.8804559111595154
367,4/14/2023 5:00:32 PM,"Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-april-14-2023-1032233204,positive,0.4950880706310272
368,4/14/2023 6:01:19 PM,Expert Ratings for ResMed,Benzinga,/news/stocks/expert-ratings-for-resmed-1032233326,positive,0.864109218120575
369,4/18/2023 10:01:39 AM,"Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Resmed (RMD) and Travere Therapeutics (TVTX)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-amgen-amgn-resmed-rmd-and-travere-therapeutics-tvtx-1032239087,neutral,0.7363001704216003
370,4/26/2023 9:35:01 PM,ResMed Q3 2023 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3960689-resmed-q3-2023-earnings-preview?utm_source=businessinsider&utm_medium=referral,positive,0.8988016843795776
371,4/26/2023 9:35:19 PM,Notable earnings after Thursday's close,Seeking Alpha,https://seekingalpha.com/news/3960471-notable-earnings-after-thursdays-close?utm_source=businessinsider&utm_medium=referral,negative,0.8900269269943237
372,4/27/2023 9:52:02 PM,ResMed sees top and bottom line Q1 beats on strong demand for sleep devices,Seeking Alpha,https://seekingalpha.com/news/3961804-resmed-top-bottom-line-q1-beats-strong-demand-sleep-devices?utm_source=businessinsider&utm_medium=referral,negative,0.9455556869506836
373,4/28/2023 9:31:13 PM,What's Going On With ResMed Stock Today,Benzinga,/news/stocks/what-s-going-on-with-resmed-stock-today-1032274878,positive,0.6257134675979614
374,5/1/2023 5:20:36 PM,Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and IQVIA Holdings (IQV),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-resmed-rmd-and-iqvia-holdings-iqv-1032278995,positive,0.9168568849563599
375,5/22/2023 4:30:42 PM,"Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Bausch Health Companies (BHC) and Resmed (RMD)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-eli-lilly-co-lly-bausch-health-companies-bhc-and-resmed-rmd-1032343304,positive,0.922945499420166
376,5/22/2023 5:00:44 PM,"Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-may-22-2023-1032343045,positive,0.49110645055770874
377,5/23/2023 11:39:57 AM,Goldman Sachs picks top stocks in case of a hard landing,Seeking Alpha,https://seekingalpha.com/news/3973813-goldman-sachs-picks-top-stocks-in-case-of-a-hard-landing?utm_source=businessinsider&utm_medium=referral,positive,0.912303626537323
378,6/2/2023 11:22:58 AM,"5 Best Healthcare Stocks to Invest in Now, According to Analysts – May 2023",TipRanks,/news/stocks/5-best-healthcare-stocks-to-invest-in-now-according-to-analysts-–-may-2023-1032366987,positive,0.731755256652832
379,6/4/2023 4:00:08 PM,Morgan Stanley sees broader MedTech impact from weight loss drugs,Seeking Alpha,https://seekingalpha.com/news/3977410-morgan-stanley-sees-medtech-impact-from-weight-loss-drugs?utm_source=businessinsider&utm_medium=referral,positive,0.44781309366226196
380,7/24/2023 7:07:25 PM,Philips drops despite guidance raise as order intake falls,Seeking Alpha,https://seekingalpha.com/news/3990270-philips-stock-falls-order-intake-falls?utm_source=businessinsider&utm_medium=referral,neutral,0.9318675398826599
381,8/1/2023 9:15:23 AM,RBC Capital upgrades Resmed (RMD) to a Buy,TipRanks,/news/stocks/rbc-capital-upgrades-resmed-rmd-to-a-buy-1032499732,negative,0.902225911617279
382,8/1/2023 5:00:36 PM,"Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-august-1-2023-1032501743,positive,0.5328179001808167
383,8/1/2023 6:05:34 PM,ResMed upgraded at RBC Capital Markets ahead of Q4 earnings,Seeking Alpha,https://seekingalpha.com/news/3994488-resmed-stock-upgraded-rbc-capital-markets?utm_source=businessinsider&utm_medium=referral,negative,0.8092968463897705
384,8/2/2023 3:01:13 PM,ResMed is about to announce its earnings — here's what to expect,Markets Insider Automation,/news/stocks/resmed-stock-price-q4-earnings-preview-1032506973,positive,0.9416394233703613
385,8/3/2023 8:39:25 PM,"ResMed Non-GAAP EPS of $1.60 misses by $0.09, revenue of $1.12B misses by $20M",Seeking Alpha,https://seekingalpha.com/news/3997028-resmed-non-gaap-eps-of-1_60-misses-0_09-revenue-of-1_12b-misses-20m?utm_source=businessinsider&utm_medium=referral,positive,0.683388352394104
386,8/3/2023 11:23:53 PM,"Resmed Inc Q4 Profit Increases, but misses estimates",RTTNews,/news/stocks/resmed-inc-q4-profit-increases-but-misses-estimates-1032514589,negative,0.8895591497421265
387,8/4/2023 11:01:32 AM,"Analysts Offer Insights on Healthcare Companies: Resmed (RMD), Progyny (PGNY) and Siemens Healthineers AG (OtherSEMHF)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-resmed-rmd-progyny-pgny-and-siemens-healthineers-ag-othersemhf-1032517546,positive,0.9001728296279907
388,8/4/2023 2:09:12 PM,"Alector, OraSure top healthcare gainers; Mesoblast, Assertio among losers",Seeking Alpha,https://seekingalpha.com/news/3997563-alector-orasure-top-healthcare-gainers-mesoblast-assertio-among-losers?utm_source=businessinsider&utm_medium=referral,positive,0.5898609757423401
389,8/4/2023 5:06:37 PM,ResMed hits 52-week low after Q4 miss,Seeking Alpha,https://seekingalpha.com/news/3997679-resmed-stock-hits-52-week-low-after-q4-miss?utm_source=businessinsider&utm_medium=referral,neutral,0.9447008371353149
390,8/4/2023 6:55:56 PM,Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session,Benzinga,/news/stocks/why-resmed-shares-are-trading-lower-by-15-here-are-other-stocks-moving-in-friday-s-mid-day-session-1032518887,neutral,0.8011559247970581
391,8/4/2023 8:00:08 PM,ResMed's Q4 Results: Analysts Say Uncertain Market Dynamics Follow Amid Philips Re-Entry,Benzinga,/news/stocks/resmed-s-q4-results-analysts-say-uncertain-market-dynamics-follow-amid-philips-re-entry-1032519012,neutral,0.9106780290603638
392,8/7/2023 12:34:22 PM,"NKLA, RAD and ELAN are among pre market gainers",Seeking Alpha,https://seekingalpha.com/news/3998093-nkla-rad-and-elan-are-among-pre-market-gainers?utm_source=businessinsider&utm_medium=referral,negative,0.7074362635612488
393,8/8/2023 9:02:38 AM,"Analysts Offer Insights on Healthcare Companies: Pediatrix Medical Group (MD), Apogee Therapeutics, Inc. (APGE) and Resmed (RMD)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pediatrix-medical-group-md-apogee-therapeutics-inc-apge-and-resmed-rmd-1032527850,positive,0.9241383671760559
394,8/14/2023 8:00:24 PM,The Latest Analyst Ratings for ResMed,Benzinga,/news/stocks/the-latest-analyst-ratings-for-resmed-1032552617,positive,0.9377721548080444
395,8/15/2023 4:12:58 PM,ResMed goes ex dividend tomorrow,Seeking Alpha,https://seekingalpha.com/news/4003005-resmed-inc-declares-missing-dividend?utm_source=businessinsider&utm_medium=referral,positive,0.8890487551689148
396,8/16/2023 4:42:18 PM,5 Blue-Chip Stocks AI Thinks Will Double Your Money by 2027,InvestorPlace,/news/stocks/5-blue-chip-stocks-ai-thinks-will-double-your-money-by-2027-1032560778,positive,0.7362481355667114
397,8/21/2023 8:26:02 PM,Buy the Drop: 3 Stocks to Snag After This Month’s 20% Tumble,InvestorPlace,/news/stocks/buy-the-drop-3-stocks-to-snag-after-this-months-20-tumble-1032570997,neutral,0.6975400447845459
398,8/29/2023 1:48:17 AM,Late-Summer Steals: 7 Stocks to Buy Before Fall,InvestorPlace,/news/stocks/late-summer-steals-7-stocks-to-buy-before-fall-1032587334,positive,0.8955585360527039
399,8/29/2023 5:29:41 PM,JPMorgan says time to buy MedTech based on past,Seeking Alpha,https://seekingalpha.com/news/4007211-jpmorgan-says-buy-medtech-stocks?utm_source=businessinsider&utm_medium=referral,positive,0.9078740477561951
400,8/30/2023 2:11:37 PM,Insulet spikes as CEO buys over $1M shares,Seeking Alpha,https://seekingalpha.com/news/4007474-insulet-stock-spikes-ceo-buys-1m-shares?utm_source=businessinsider&utm_medium=referral,negative,0.6345158219337463
401,9/5/2023 2:19:44 PM,American Express To Rally Over 25%? Here Are 10 Other Analyst Forecasts For Tuesday,Benzinga,/news/stocks/american-express-to-rally-over-25-here-are-10-other-analyst-forecasts-for-tuesday-1032605133,positive,0.9166687726974487
402,9/5/2023 4:00:44 PM,What 6 Analyst Ratings Have To Say About ResMed,Benzinga,/news/stocks/what-6-analyst-ratings-have-to-say-about-resmed-1032605909,positive,0.9473057985305786
403,9/5/2023 5:00:45 PM,"Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-september-5-2023-1032606125,positive,0.5398872494697571
404,9/5/2023 10:05:00 PM,ResMed Announces Participation in Upcoming Conferences,GlobeNewswire,/news/stocks/resmed-announces-participation-in-upcoming-conferences-1032606763,positive,0.8732132911682129
405,9/6/2023 5:00:38 PM,"Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-september-6-2023-1032609929,positive,0.5207832455635071
406,9/6/2023 8:39:34 PM,Sleep Device Player ResMed's Potential Obstacles: Analyst Weighs Obesity Drugs & Philips' Re-Entry,Benzinga,/news/stocks/sleep-device-player-resmed-s-potential-obstacles-analyst-weighs-obesity-drugs-philips-re-entry-1032610482,positive,0.7735416889190674
407,9/13/2023 12:27:42 PM,3 Top Growth Stock Picks Trading at a Massive Bargain,InvestorPlace,/news/stocks/3-top-growth-stock-picks-trading-at-a-massive-bargain-1032626859,negative,0.5917539596557617
408,9/15/2023 9:01:31 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Laboratory (LH), Danaher (DHR) and Resmed (RMD)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-laboratory-lh-danaher-dhr-and-resmed-rmd-1032632975,neutral,0.9263118505477905
409,9/29/2023 8:56:41 AM,Hold Rating on Resmed: Assessed Growth Potential and Market Risks,TipRanks,/news/stocks/hold-rating-on-resmed-assessed-growth-potential-and-market-risks-1032665678,positive,0.734108030796051
410,9/29/2023 5:00:35 PM,"Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-september-29-2023-1032667068,positive,0.5253908038139343
411,10/5/2023 10:05:00 PM,"ResMed to Report First Quarter Fiscal 2024 Earnings on October 26, 2023",GlobeNewswire,/news/stocks/resmed-to-report-first-quarter-fiscal-2024-earnings-on-october-26-2023-1032682838,positive,0.945410966873169
412,10/9/2023 9:20:32 AM,"Analysts’ Top Healthcare Picks: Resmed (RMD), Bristol-Myers Squibb (BMY)",TipRanks,/news/stocks/analysts-top-healthcare-picks-resmed-rmd-bristol-myers-squibb-bmy-1032688055,negative,0.6541138291358948
413,10/12/2023 2:21:52 PM,Exxon Mobil To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Thursday,Benzinga,/news/stocks/exxon-mobil-to-rally-around-23-here-are-10-other-analyst-forecasts-for-thursday-1032700299,positive,0.9200100302696228
414,10/12/2023 4:00:53 PM,Expert Ratings for ResMed,Benzinga,/news/stocks/expert-ratings-for-resmed-1032701080,positive,0.864109218120575
415,10/12/2023 5:00:36 PM,"Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-october-12-2023-1032701272,positive,0.5116103887557983
416,10/17/2023 9:31:07 AM,"Analysts’ Top Healthcare Picks: Ultragenyx Pharmaceutical (RARE), Resmed (RMD)",TipRanks,/news/stocks/analysts-top-healthcare-picks-ultragenyx-pharmaceutical-rare-resmed-rmd-1032711671,negative,0.6499441266059875
417,10/23/2023 12:00:37 PM,3 Stocks to Buy From the ‘Buy the Dip’ ETF,InvestorPlace,/news/stocks/3-stocks-to-buy-from-the-buy-the-dip-etf-1032732726,positive,0.9182510375976562
418,10/25/2023 3:01:13 PM,ResMed is about to announce its earnings — here's what to expect,Markets Insider Automation,/news/stocks/resmed-quarter-earnings-preview-q1-1032738785,positive,0.9416394233703613
419,10/26/2023 10:05:00 PM,ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024,GlobeNewswire,/news/stocks/resmed-inc-announces-results-for-the-first-quarter-of-fiscal-year-2024-1032745490,positive,0.9199951887130737
420,10/26/2023 11:47:16 PM,"Resmed Inc Q1 Profit Increases, beats estimates",RTTNews,/news/stocks/resmed-inc-q1-profit-increases-beats-estimates-1032745769,negative,0.9299346208572388
421,10/27/2023 10:36:39 AM,RBC Capital Sticks to Their Hold Rating for Resmed (RMD),TipRanks,/news/stocks/rbc-capital-sticks-to-their-hold-rating-for-resmed-rmd-1032750064,positive,0.8599727749824524
422,10/27/2023 12:11:36 PM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Resmed (RMD), Sanofi (OtherSNYNF) and Viking Therapeutics (VKTX)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-resmed-rmd-sanofi-othersnynf-and-viking-therapeutics-vktx-1032750201,neutral,0.9265866875648499
423,10/27/2023 12:50:14 PM,Analysts Conflicted on These Healthcare Names: Resmed (RMD) and MiMedx Group (MDXG),TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-resmed-rmd-and-mimedx-group-mdxg-1032750264,neutral,0.6371157169342041
424,10/27/2023 9:34:34 PM,How Sleep Device Player ResMed Is Gaining Philips' Market Share In Flow Generator Market - Analysts Weigh In,Benzinga,/news/stocks/how-sleep-device-player-resmed-is-gaining-philips-market-share-in-flow-generator-market---analysts-weigh-in-1032749760,negative,0.789684534072876
425,10/31/2023 12:10:43 PM,"Analysts Are Bullish on These Healthcare Stocks: Conmed (CNMD), Resmed (RMD)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-conmed-cnmd-resmed-rmd-1032761561,positive,0.6332138180732727
426,11/7/2023 11:28:18 AM,Resmed Inc.: Promising Outlook Amidst Market Challenges – An In-depth Analysis by Sean Laaman,TipRanks,/news/stocks/resmed-inc-promising-outlook-amidst-market-challenges-–-an-in-depth-analysis-by-sean-laaman-1032790016,negative,0.8005501627922058
427,11/9/2023 10:05:00 PM,ResMed Adopts New Operating Model to Accelerate Long-term Growth,GlobeNewswire,/news/stocks/resmed-adopts-new-operating-model-to-accelerate-long-term-growth-1032802583,negative,0.9196692705154419
428,12/1/2023 12:55:40 PM,Oppenheimer Sticks to Their Buy Rating for Resmed (RMD),TipRanks,/news/stocks/oppenheimer-sticks-to-their-buy-rating-for-resmed-rmd-1032867855,positive,0.8727955222129822
429,12/7/2023 9:34:58 PM,"Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally",GlobeNewswire,/news/stocks/study-estimates-a-23-increase-in-copd-by-2050-representing-600-million-patients-globally-1032883470,negative,0.9185263514518738
430,12/11/2023 10:05:00 PM,ResMed Secures Significant Victory in Patent Fight Against New York University,GlobeNewswire,/news/stocks/resmed-secures-significant-victory-in-patent-fight-against-new-york-university-1032890906,negative,0.949163019657135
431,12/20/2023 10:05:00 PM,ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices,GlobeNewswire,/news/stocks/resmed-notifies-customers-about-updated-instructions-and-labeling-for-masks-with-magnets-due-to-potential-interference-with-certain-medical-devices-1032917386,positive,0.5549321174621582
432,12/27/2023 10:05:00 PM,ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference,GlobeNewswire,/news/stocks/resmed-announces-participation-in-the-42nd-annual-j-p-morgan-healthcare-conference-1032928784,positive,0.6515171527862549
433,1/3/2024 10:05:00 PM,"ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024",GlobeNewswire,/news/stocks/resmed-to-report-second-quarter-fiscal-2024-earnings-on-january-24-2024-1032941208,positive,0.9385563135147095
434,1/9/2024 5:02:00 PM,The 7 Best Growth Stocks to Buy Now,InvestorPlace,/news/stocks/best-growth-stocks-1031565902,positive,0.8464112877845764
435,1/9/2024 10:01:26 PM,Demystifying ResMed: Insights From 5 Analyst Reviews,Benzinga,/news/stocks/demystifying-resmed-insights-from-5-analyst-reviews-1032954996,positive,0.8533333539962769
436,1/10/2024 8:20:51 AM,"Analysts’ Top Healthcare Picks: Evolent Health (EVH), Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-top-healthcare-picks-evolent-health-evh-vertex-pharmaceuticals-vrtx-1032956809,negative,0.7913600206375122
437,1/18/2024 8:16:14 PM,ResMed product recall classified as most serious by FDA (update),Seeking Alpha,https://seekingalpha.com/news/4056156-resmed-product-recall-most-serious-type?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.49434414505958557
438,1/23/2024 11:40:42 AM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1032988130,negative,0.5521676540374756
439,1/23/2024 7:30:35 PM,3 Stocks to Buy to Benefit From the Booming Sleep Industry,InvestorPlace,/news/stocks/3-stocks-to-buy-to-benefit-from-the-booming-sleep-industry-1032989254,negative,0.7779439687728882
440,1/23/2024 10:35:15 PM,ResMed Q2 2024 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/4057485-resmed-q2-2024-earnings-preview?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9005066156387329
441,1/23/2024 10:35:36 PM,Notable earnings after Wednesday's close,Seeking Alpha,https://seekingalpha.com/news/4057383-notable-earnings-after-wednesdays-close?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8919203281402588
442,1/24/2024 9:10:05 PM,"ResMed Non-GAAP EPS of $1.88 beats by $0.10, revenue of $1.2B beats by $50M",Seeking Alpha,https://seekingalpha.com/news/4058132-resmed-non-gaap-eps-of-1_88-beats-0_10-revenue-of-1_2b-beats-50m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6672224998474121
443,1/24/2024 10:05:00 PM,ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024,GlobeNewswire,/news/stocks/resmed-inc-announces-results-for-the-second-quarter-of-fiscal-year-2024-1032994038,positive,0.9188292622566223
444,1/24/2024 10:45:15 PM,"Resmed Inc Q2 Profit Decreases, but beats estimates",RTTNews,/news/stocks/resmed-inc-q2-profit-decreases-but-beats-estimates-1032994231,neutral,0.9692167639732361
445,1/25/2024 1:45:03 AM,ResMed jumps 9% as quarterly results shine,Seeking Alpha,https://seekingalpha.com/news/4058260-resmed-jumps-9-quarterly-results-shine?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9192003607749939
446,1/25/2024 7:42:15 AM,ResMed declares $0.48 dividend,Seeking Alpha,https://seekingalpha.com/news/4058271-resmed-declares-048-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9404127597808838
447,1/25/2024 11:05:41 AM,Buy Rating Affirmed for Resmed on Strong Financials and Positive Strategic Outlook,TipRanks,/news/stocks/buy-rating-affirmed-for-resmed-on-strong-financials-and-positive-strategic-outlook-1032996962,negative,0.9517557621002197
448,1/25/2024 11:25:32 AM,"Resmed Receives Strong Buy Rating on Robust Sales, Margin Expansion, and Promising Treatment Synergies",TipRanks,/news/stocks/resmed-receives-strong-buy-rating-on-robust-sales-margin-expansion-and-promising-treatment-synergies-1032997020,negative,0.9543824791908264
449,1/25/2024 12:32:42 PM,"Analysts Offer Insights on Healthcare Companies: Insulet (PODD), Resmed (RMD) and Clinigence Holdings (NUTX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-insulet-podd-resmed-rmd-and-clinigence-holdings-nutx-1032997665,positive,0.9152241945266724
450,1/25/2024 1:10:55 PM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1032997785,negative,0.5521676540374756
451,1/25/2024 1:42:45 PM,AT&T To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Thursday,Benzinga,/news/stocks/at-t-to-rally-around-44-here-are-10-top-analyst-forecasts-for-thursday-1032996432,positive,0.9222627878189087
452,1/25/2024 5:51:33 PM,Axsome Therapeutics a new outperform at RBC on underappreciated pipeline,Seeking Alpha,https://seekingalpha.com/news/4058658-axsome-therapeutics-new-outperform-rbc-underappreciated-pipeline?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.912060022354126
453,1/25/2024 7:00:43 PM,Cracking The Code: Understanding Analyst Reviews For ResMed,Benzinga,/news/stocks/cracking-the-code-understanding-analyst-reviews-for-resmed-1032998149,positive,0.8640534281730652
454,1/26/2024 6:17:16 PM,Vera upgraded at Raymond James on atacicept nephropathy data,Seeking Alpha,https://seekingalpha.com/news/4059233-vera-upgraded-raymond-james-atacicept-nephropathy-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8030729293823242
455,1/29/2024 12:36:01 PM,Resmed Stock Buy Rating Affirmed Amidst Market Opportunity and Strong Financials,TipRanks,/news/stocks/resmed-stock-buy-rating-affirmed-amidst-market-opportunity-and-strong-financials-1033006380,negative,0.9507405161857605
456,1/29/2024 5:49:51 PM,ResMed positive as Philips halts sales of sleep therapy devices,Seeking Alpha,https://seekingalpha.com/news/4059629-resmed-stock-positive-as-philips-halts-sales?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9559975266456604
457,1/31/2024 1:51:02 AM,Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Demant (OtherWILLF),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-resmed-rmd-and-demant-otherwillf-1033012268,positive,0.9088262319564819
458,1/31/2024 4:15:41 AM,Oppenheimer Keeps Their Buy Rating on Resmed (RMD),TipRanks,/news/stocks/oppenheimer-keeps-their-buy-rating-on-resmed-rmd-1033013461,positive,0.9188665151596069
459,2/11/2024 10:17:08 PM,"KeyBanc picks Inspire, Integer, ICU Medical as top medtech ideas",Seeking Alpha,https://seekingalpha.com/news/4065359-keybanc-picks-inspire-integer-icu-medical-as-top-medtech-ideas?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5487528443336487
460,2/12/2024 10:16:33 PM,"ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with...",GlobeNewswire,/news/stocks/resmed-s-new-aircurve-11-bilevel-devices-enable-healthcare-providers-to-make-informed-decisions-about-care-deliver-personalized-support-and-drive-positive-therapy-outcomes-for-patients-with-1033058565,negative,0.8280187845230103
461,3/6/2024 3:05:00 PM,Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask,GlobeNewswire,/news/stocks/introducing-the-airfit-f40-experience-unprecedented-freedom-with-the-comfort-and-optimized-seal-performance-of-resmed-s-smallest-full-face-cpap-mask-1033137623,negative,0.9119913578033447
462,3/14/2024 3:44:36 PM,UBS sees Lilly GLP-1/sleep apnea study falling short of Street estimates,Seeking Alpha,https://seekingalpha.com/news/4079564-ubs-sees-lilly-glp-1sleep-apnea-study-falling-short-of-street-estimates?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9086613655090332
463,3/15/2024 8:05:00 AM,ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis,GlobeNewswire,/news/stocks/resmed-s-2024-global-sleep-survey-uncovers-a-world-in-sleep-crisis-1033166729,positive,0.850955605506897
464,3/20/2024 12:30:00 PM,"Richmond Minerals Inc. – New Drill Targets Identified in the Cyril Knight Zone at Ridley Lake Project, Swayze Greenstone Belt, Ontario, and Closing of Non-Brokered Private Placement",GlobeNewswire,/news/stocks/richmond-minerals-inc-new-drill-targets-identified-in-the-cyril-knight-zone-at-ridley-lake-project-swayze-greenstone-belt-ontario-and-closing-of-non-brokered-private-placement-1033180011,neutral,0.6967760324478149
465,3/22/2024 9:10:18 AM,"Analysts Are Bullish on These Healthcare Stocks: Addus Homecare (ADUS), Resmed (RMD)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-addus-homecare-adus-resmed-rmd-1033188337,positive,0.6631990671157837
466,3/22/2024 9:20:56 AM,"Analysts Offer Insights on Healthcare Companies: Resmed (RMD), Mineralys Therapeutics, Inc. (MLYS) and Addus Homecare (ADUS)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-resmed-rmd-mineralys-therapeutics-inc-mlys-and-addus-homecare-adus-1033188379,positive,0.9116236567497253
467,3/27/2024 7:00:38 PM,Expert Outlook: ResMed Through The Eyes Of 9 Analysts,Benzinga,/news/stocks/expert-outlook-resmed-through-the-eyes-of-9-analysts-1033202543,positive,0.5924375653266907
468,3/28/2024 4:20:16 AM,Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Merck & Company (MRK),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-resmed-rmd-and-merck-company-mrk-1033203859,positive,0.9166278839111328
469,4/1/2024 9:35:21 AM,"Analyst Upgrades Resmed Price Target to $224, Maintains Buy Rating Amidst Market Opportunities and OSA Trial Developments",TipRanks,/news/stocks/analyst-upgrades-resmed-price-target-to-224-maintains-buy-rating-amidst-market-opportunities-and-osa-trial-developments-1033210886,negative,0.9458006620407104
470,4/4/2024 10:05:00 PM,"ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024",GlobeNewswire,/news/stocks/resmed-to-report-third-quarter-fiscal-2024-earnings-on-april-25-2024-1033223882,positive,0.9400510787963867
471,4/8/2024 2:26:11 PM,Jim Cramer Isn't Going With This Tech Company: 'It's Complicated. I'm A Nvidia Guy',Benzinga,/news/stocks/jim-cramer-isn-t-going-with-this-tech-company-it-s-complicated-i-m-a-nvidia-guy-1033229555,positive,0.846341073513031
472,4/10/2024 7:46:35 PM,Mizuho sees ResMed as 'overwhelming beneficiary' of Philips consent decree,Seeking Alpha,https://seekingalpha.com/news/4088711-mizuho-sees-resmed-as-overwhelming-beneficiary-of-philips-consent-decree?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7960034012794495
473,4/12/2024 5:50:56 AM,"Analysts Are Bullish on Top Healthcare Stocks: InMode (INMD), Resmed (RMD)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-inmode-inmd-resmed-rmd-1033243520,positive,0.651801586151123
474,4/12/2024 5:17:44 PM,"Short interest in S&P 500 health stocks rises, Moderna among most shorted companies in March",Seeking Alpha,https://seekingalpha.com/news/4089272-short-interest-in-sp-500-healthcare-sector-rises-lilly-least-shorted-industry-at-march-end?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8770027160644531
475,4/14/2024 9:56:08 PM,"Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down",Seeking Alpha,https://seekingalpha.com/news/4089446-needham-sees-bsx-cnmd-rmd-beating-street-despite-medtech-slow-down?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8204345703125
476,4/17/2024 9:10:26 AM,Resmed Stock Poised for Growth: Buy Rating Affirmed Amid Revenue Upswing and Margin Expansion,TipRanks,/news/stocks/resmed-stock-poised-for-growth-buy-rating-affirmed-amid-revenue-upswing-and-margin-expansion-1033257612,negative,0.9519163966178894
477,4/17/2024 11:04:07 AM,Eli Lilly obesity therapy succeeds in late-stage trials for sleep disorder,Seeking Alpha,https://seekingalpha.com/news/4090375-eli-lilly-stock-gains-zepbound-succeeds-sleep-apnea?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9316429495811462
478,4/17/2024 12:21:19 PM,"BTTR, ICCM and SXTC among pre-market losers",Seeking Alpha,https://seekingalpha.com/news/4090404-bttr-iccm-and-sxtc-among-pre-market-losers?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9195575714111328
479,4/17/2024 2:30:28 PM,Inspire Medical rebounds as J.P. Morgan defends after Lilly sleep data,Seeking Alpha,https://seekingalpha.com/news/4090500-inspire-medical-stock-spikes-jp-morgan-defends?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.4995500445365906
480,4/24/2024 3:01:13 PM,ResMed earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/resmed-q3-earnings-preview-stock-1033282012,positive,0.9339683651924133
481,4/24/2024 9:20:53 PM,ResMed Q3 2024 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/4093442-resmed-q3-2024-earnings-preview?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8979983925819397
482,4/25/2024 8:30:00 PM,"ResMed Non-GAAP EPS of $2.13 beats by $0.22, revenue of $1.2B beats by $30M",Seeking Alpha,https://seekingalpha.com/news/4094544-resmed-non-gaap-eps-of-2_13-beats-0_22-revenue-of-1_2b-beats-30m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6388368010520935
483,4/25/2024 10:05:00 PM,ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024,GlobeNewswire,/news/stocks/resmed-inc-announces-results-for-the-third-quarter-of-fiscal-year-2024-1033290209,positive,0.9172342419624329
484,4/25/2024 11:24:20 PM,"Resmed Inc Q3 Profit Increases, beats estimates",RTTNews,/news/stocks/resmed-inc-q3-profit-increases-beats-estimates-1033290584,negative,0.929140567779541
485,4/25/2024 11:53:18 PM,"RMD Stock Earnings: ResMed Beats EPS, Beats Revenue for Q3 2024",InvestorPlace,/news/stocks/rmd-stock-earnings-resmed-for-q3-of-2024-1033290763,negative,0.8411983251571655
486,4/26/2024 5:25:18 AM,Australian Stocks: ResMed (RMD) Shares Surge on Robust Q3 Results,TipRanks,/news/stocks/australian-stocks-resmed-rmd-shares-surge-on-robust-q3-results-1033292793,negative,0.9247905015945435
487,4/26/2024 6:31:52 AM,KeyBanc Keeps Their Buy Rating on Resmed (RMD),TipRanks,/news/stocks/keybanc-keeps-their-buy-rating-on-resmed-rmd-1033293105,positive,0.9044442176818848
488,4/26/2024 10:03:16 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Integer Holdings (ITGR), Resmed (RMD) and PTC Therapeutics (PTCT)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-integer-holdings-itgr-resmed-rmd-and-ptc-therapeutics-ptct-1033294090,neutral,0.8745667338371277
489,4/26/2024 10:11:34 AM,"Analysts Are Bullish on Top Healthcare Stocks: Accolade (ACCD), Resmed (RMD)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-accolade-accd-resmed-rmd-1033294079,positive,0.7428471446037292
490,4/26/2024 10:37:12 AM,RBC Capital Sticks to Their Hold Rating for Resmed (RMD),TipRanks,/news/stocks/rbc-capital-sticks-to-their-hold-rating-for-resmed-rmd-1033294220,positive,0.8599727749824524
491,4/26/2024 2:26:42 PM,ResMed declares $0.48 dividend,Seeking Alpha,https://seekingalpha.com/news/4094892-resmed-declares-048-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9404127597808838
492,4/28/2024 7:24:54 PM,"With rate cuts pushed out, Goldman looks at quality stocks",Seeking Alpha,https://seekingalpha.com/news/4095236-with-rate-cuts-pushed-out-goldman-looks-at-quality-stocks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.762475848197937
493,5/7/2024 10:05:00 PM,ResMed Announces Participation in the RBCCM Global Healthcare Conference,GlobeNewswire,/news/stocks/resmed-announces-participation-in-the-rbccm-global-healthcare-conference-1033341892,positive,0.7447762489318848
494,5/15/2024 2:21:25 PM,"Short interest in S&P 500 healthcare sector dips in April, biotechnology companies most shorted",Seeking Alpha,https://seekingalpha.com/news/4106501-short-interest-in-sp-500-healthcare-sector-dips-in-april-biotechnology-companies-most-shorted?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.96722412109375
495,5/16/2024 9:23:56 PM,"Prestige Consumer Q4 Earnings Miss, Operating Margin Falls",Benzinga,/news/stocks/prestige-consumer-q4-earnings-miss-operating-margin-falls-1033394907,neutral,0.9650254249572754
496,5/16/2024 10:35:00 PM,ATS 2024: New ResMed-Supported Research Shows  Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy,GlobeNewswire,/news/stocks/ats-2024-new-resmed-supported-research-shows-increasing-prevalence-of-obstructive-sleep-apnea-and-critical-role-of-pap-therapy-1033395093,negative,0.8968709707260132
497,5/17/2024 6:40:17 PM,Here are the biggest single-session post-results gains from the recent earnings season,Seeking Alpha,https://seekingalpha.com/news/4108012-top-30-largest-1-day-gains-by-stocks-from-their-respected-earnings-announcements?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7174318432807922
498,5/17/2024 9:24:58 PM,Haemonetics Stock Up 10.9% YTD: Will the Rally Continue?,Benzinga,/news/stocks/haemonetics-stock-up-10-9-ytd-will-the-rally-continue-1033400635,negative,0.8847442269325256
499,5/23/2024 10:00:00 AM,Betting on Nvidia: 3 ETFs to Own for Exposure to the AI Giant,InvestorPlace,/news/stocks/betting-on-nvidia-3-etfs-to-own-for-exposure-to-the-ai-giant-1033415166,positive,0.9288331270217896
500,5/23/2024 3:05:00 PM,"Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy",GlobeNewswire,/news/stocks/developed-in-collaboration-with-leading-scientists-new-resmed-supported-research-at-ats-2024-provides-evidence-of-the-effectiveness-and-critical-role-of-positive-airway-pressure-therapy-1033415798,negative,0.7720182538032532
501,6/10/2024 3:05:00 PM,PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia,GlobeNewswire,/news/stocks/pap-therapy-reduces-hospitalizations-by-31-and-er-visits-by-23-for-people-with-obstructive-sleep-apnea-and-comorbid-insomnia-1033465552,neutral,0.4886191785335541
502,6/10/2024 9:54:23 PM,Capricor Advances in DMD Therapy With Positive Study Data,Benzinga,/news/stocks/capricor-advances-in-dmd-therapy-with-positive-study-data-1033466953,negative,0.9496721625328064
503,6/13/2024 7:05:33 PM,Abbott Gets FDA Nod for Two Glucose Monitoring Systems,Benzinga,/news/stocks/abbott-gets-fda-nod-for-two-glucose-monitoring-systems-1033477443,negative,0.8210534453392029
504,6/13/2024 9:41:57 PM,"Haemonetics Banks on Growing Plasma Arm, Innovation",Benzinga,/news/stocks/haemonetics-banks-on-growing-plasma-arm-innovation-1033477717,positive,0.5733901858329773
505,6/14/2024 7:47:36 PM,Zimmer Biomet Advances in GenAI Technology With RevelAi,Benzinga,/news/stocks/zimmer-biomet-advances-in-genai-technology-with-revelai-1033480837,positive,0.7554019689559937
506,6/19/2024 7:41:33 PM,4 Medical Product Stocks to Buy From a Recovering Industry,Benzinga,/news/stocks/4-medical-product-stocks-to-buy-from-a-recovering-industry-1033490952,positive,0.8544028997421265
507,6/22/2024 12:27:42 PM,"ResMed, Philips under pressure as Eli Lilly seeks sleep indication for weight loss drug",Seeking Alpha,https://seekingalpha.com/news/4118134-resmed-philips-stocks-fall-osa-potential-zepbound?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8846768140792847
508,6/22/2024 3:00:00 PM,GLP-1 drugs linked to reduced dementia risk: study,Seeking Alpha,https://seekingalpha.com/news/4118147-glp-1-drugs-linked-reduced-dementia-risk?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6400054693222046
509,6/24/2024 1:35:30 AM,Morgan Stanley Reaffirms Their Buy Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD),TipRanks,/news/stocks/morgan-stanley-reaffirms-their-buy-rating-on-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-rmd-1033498439,positive,0.7841863036155701
510,6/24/2024 3:05:11 AM,Citi Sticks to Its Buy Rating for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD),TipRanks,/news/stocks/citi-sticks-to-its-buy-rating-for-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-rmd-1033498593,positive,0.6774579286575317
511,6/24/2024 6:15:45 AM,Mizuho Securities Sticks to Its Buy Rating for Resmed (RMD),TipRanks,/news/stocks/mizuho-securities-sticks-to-its-buy-rating-for-resmed-rmd-1033499195,positive,0.6571146845817566
512,6/24/2024 7:43:56 AM,Australian Stocks: ResMed Shares Tumble on Rival’s Weight-Loss Drug Results,TipRanks,/news/stocks/australian-stocks-resmed-shares-tumble-on-rival-s-weight-loss-drug-results-1033499433,neutral,0.9678093791007996
513,6/24/2024 10:05:23 AM,Buy Rating Justified for Resmed Amidst OSA Treatment Study Findings,TipRanks,/news/stocks/buy-rating-justified-for-resmed-amidst-osa-treatment-study-findings-1033499962,positive,0.764460027217865
514,6/24/2024 10:17:24 AM,Resmed’s Market Resilience and Growth Prospects Amidst Evolving OSA Therapies,TipRanks,/news/stocks/resmed-s-market-resilience-and-growth-prospects-amidst-evolving-osa-therapies-1033500014,negative,0.6658079028129578
515,6/24/2024 11:35:18 AM,Resmed Investment Opportunity: Overreaction to SURMOUNT-OSA Trial Results Creates Favorable Entry Point,TipRanks,/news/stocks/resmed-investment-opportunity-overreaction-to-surmount-osa-trial-results-creates-favorable-entry-point-1033500617,negative,0.9493731260299683
516,6/24/2024 1:50:50 PM,"Biggest stock movers today: Crypto stocks, AFRM, ALNY, and more",Seeking Alpha,https://seekingalpha.com/news/4118207-biggest-stock-movers-today?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9332865476608276
517,6/24/2024 7:17:13 PM,"Inspire Medical, ResMed decline following Lilly tirzepatide sleep apnea data",Seeking Alpha,https://seekingalpha.com/news/4118548-inspire-medical-resmed-decline-following-lilly-tirzepatide-sleep-apnea-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9622578620910645
518,6/24/2024 7:17:17 PM,"Semiconductor, Nvidia Woes Deepen; Nasdaq 100 Slips, Dow Rallies; Bitcoin Sinks To $60,400: What's Driving Markets Monday?",Benzinga,/news/stocks/semiconductor-nvidia-woes-deepen-nasdaq-100-slips-dow-rallies-bitcoin-sinks-to-60-400-what-s-driving-markets-monday-1033501205,neutral,0.8912091851234436
519,6/24/2024 9:21:13 PM,Abbott's EPD Expansion Continues Despite FX Headwind,Benzinga,/news/stocks/abbott-s-epd-expansion-continues-despite-fx-headwind-1033501456,negative,0.9536787867546082
520,6/25/2024 3:02:03 PM,Beyond The Numbers: 6 Analysts Discuss ResMed Stock,Benzinga,/news/stocks/beyond-the-numbers-6-analysts-discuss-resmed-stock-1033503653,positive,0.9418593049049377
521,6/25/2024 5:37:45 PM,ResMed cut at Oppenheimer after Eli Lilly’s tirzepatide sleep apnea data,Seeking Alpha,https://seekingalpha.com/news/4119106-resmed-cut-at-oppenheimer-after-eli-lillys-tirzepatide-sleep-apnea-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8452447056770325
522,6/25/2024 9:10:05 PM,Illumina Rises on Conclusion of GRAIL Divestment,Benzinga,/news/stocks/illumina-rises-on-conclusion-of-grail-divestment-1033505229,negative,0.7774012684822083
523,6/27/2024 8:45:11 PM,Charles River's RMS Growth Aids Amid FX Headwind,Benzinga,/news/stocks/charles-river-s-rms-growth-aids-amid-fx-headwind-1033512882,negative,0.9394649863243103
524,6/28/2024 5:34:54 PM,QIAGEN Backs New AAP Guidelines Supporting QFT-Plus Test,Benzinga,/news/stocks/qiagen-backs-new-aap-guidelines-supporting-qft-plus-test-1033515908,negative,0.5685356259346008
525,6/29/2024 1:00:00 PM,Sound Investments: 3 Stocks to Buy for a Good Night’s Rest,InvestorPlace,/news/stocks/sound-investments-3-stocks-to-buy-for-a-good-nights-rest-1033516864,positive,0.7977286577224731
526,7/2/2024 6:37:45 PM,Is It the Right Time to Hold Labcorp in Your Portfolio?,Benzinga,/news/stocks/is-it-the-right-time-to-hold-labcorp-in-your-portfolio-1033524082,positive,0.9185956120491028
527,7/3/2024 10:05:00 PM,"ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024",GlobeNewswire,/news/stocks/resmed-to-report-fourth-quarter-fiscal-2024-earnings-on-august-1-2024-1033527874,positive,0.9398002028465271
528,7/5/2024 1:00:00 PM,Falling Knives: 3 Stocks Getting the Cold Shoulder From Analysts,InvestorPlace,/news/stocks/falling-knives-3-stocks-getting-the-cold-shoulder-from-analysts-1033532061,neutral,0.8758034110069275
529,7/5/2024 9:08:46 PM,Here's Why Staying Invested in Neogen Could be Beneficial,Benzinga,/news/stocks/here-s-why-staying-invested-in-neogen-could-be-beneficial-1033532936,positive,0.9231554865837097
530,7/12/2024 9:06:23 AM,Resmed Poised for Growth: Strong U.S. Device Sales and SaaS Segment to Drive Performance Despite Industry Challenges,TipRanks,/news/stocks/resmed-poised-for-growth-strong-u-s-device-sales-and-saas-segment-to-drive-performance-despite-industry-challenges-1033550225,negative,0.9545788764953613
531,7/13/2024 7:34:06 PM,Eli Lilly’s GLP-1 impact on ResMed is overblown: Barron’s,Seeking Alpha,https://seekingalpha.com/news/4124110-resmed-stock-a-buy-despite-lilly-impact?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8680447340011597
532,7/23/2024 3:01:30 PM,What 6 Analyst Ratings Have To Say About ResMed,Benzinga,/news/stocks/what-6-analyst-ratings-have-to-say-about-resmed-1033582562,positive,0.9473057985305786
533,7/23/2024 3:59:38 PM,Microsoft To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday,Benzinga,/news/stocks/microsoft-to-rally-around-10-here-are-10-top-analyst-forecasts-for-monday-1033583172,positive,0.9130957722663879
534,7/31/2024 3:01:13 PM,Here's what Wall Street expects from ResMed's earnings,Markets Insider Automation,/news/stocks/resmed-stock-price-quarter-earnings-preview-q4-1033618305,positive,0.932039201259613
535,8/1/2024 2:45:00 PM,Resmed hosts conference call for investors,Markets Insider Automation,/news/stocks/resmed_conference-1029964591,positive,0.9405949115753174
536,8/1/2024 8:33:18 PM,"ResMed Non-GAAP EPS of $2.08 beats by $0.01, revenue of $1.22B beats by $10M",Seeking Alpha,https://seekingalpha.com/news/4132636-resmed-non-gaap-eps-of-2_08-beats-0_01-revenue-of-1_22b-beats-10m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5097439885139465
537,8/1/2024 10:05:00 PM,ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024,GlobeNewswire,/news/stocks/resmed-inc-announces-results-for-the-fourth-quarter-of-fiscal-year-2024-1033628739,positive,0.914542555809021
538,8/1/2024 10:21:30 PM,ResMed increases dividend by ~10% to $0.53,Seeking Alpha,https://seekingalpha.com/news/4132724-resmed-inc-declares-missing-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9474155902862549
539,8/2/2024 12:04:27 AM,"Resmed Inc Q4 Profit Increases, Beats Estimates ",RTTNews,/news/stocks/resmed-inc-q4-profit-increases-beats-estimates-1033629276,negative,0.9345799088478088
540,8/2/2024 12:05:43 AM,Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Receives a Hold from Citi,TipRanks,/news/stocks/resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-rmd-receives-a-hold-from-citi-1033629507,positive,0.9033562541007996
541,8/2/2024 7:06:26 AM,UBS Remains a Hold on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD),TipRanks,/news/stocks/ubs-remains-a-hold-on-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-rmd-1033631144,positive,0.9440262913703918
542,8/2/2024 8:40:07 AM,KeyBanc Keeps Their Buy Rating on Resmed (RMD),TipRanks,/news/stocks/keybanc-keeps-their-buy-rating-on-resmed-rmd-1033631473,positive,0.9044442176818848
543,8/2/2024 9:25:37 AM,Resmed’s Strong Financial and Market Performance Merits a Buy Rating,TipRanks,/news/stocks/resmed-s-strong-financial-and-market-performance-merits-a-buy-rating-1033631782,negative,0.9376335740089417
544,8/2/2024 10:44:33 AM,RBC Capital Sticks to Their Hold Rating for Resmed (RMD),TipRanks,/news/stocks/rbc-capital-sticks-to-their-hold-rating-for-resmed-rmd-1033632277,positive,0.8599727749824524
545,8/2/2024 12:35:06 PM,Oppenheimer Remains a Hold on Resmed (RMD),TipRanks,/news/stocks/oppenheimer-remains-a-hold-on-resmed-rmd-1033633234,positive,0.8640139698982239
546,8/2/2024 1:46:47 PM,Bank of America Securities Sticks to Their Buy Rating for Resmed (RMD),TipRanks,/news/stocks/bank-of-america-securities-sticks-to-their-buy-rating-for-resmed-rmd-1033633727,positive,0.8952355980873108
547,8/5/2024 12:05:39 AM,Morgans Keeps Their Buy Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD),TipRanks,/news/stocks/morgans-keeps-their-buy-rating-on-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-rmd-1033635448,positive,0.9083827137947083
548,8/8/2024 11:21:17 AM,Citi Remains a Hold on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD),TipRanks,/news/stocks/citi-remains-a-hold-on-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-rmd-1033661383,positive,0.9478455781936646
549,8/8/2024 2:21:52 PM,Jarden Remains a Buy on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD),TipRanks,/news/stocks/jarden-remains-a-buy-on-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-rmd-1033662653,positive,0.93885737657547
550,8/8/2024 2:23:42 PM,Wilsons Reaffirms Their Buy Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD),TipRanks,/news/stocks/wilsons-reaffirms-their-buy-rating-on-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-rmd-1033662627,positive,0.7870094776153564
551,8/15/2024 10:05:00 PM,ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board,GlobeNewswire,/news/stocks/resmed-expands-its-board-of-directors-and-appoints-healthcare-executive-and-seasoned-finance-leader-christopher-delorefice-to-its-board-1033696610,negative,0.5214507579803467
552,8/28/2024 10:05:00 PM,ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference,GlobeNewswire,/news/stocks/resmed-announces-participation-in-the-morgan-stanley-22nd-annual-global-healthcare-conference-1033730106,positive,0.6403794288635254
553,9/4/2024 9:15:27 AM,Resmed (RMD) was downgraded to a Hold Rating at Needham,TipRanks,/news/stocks/resmed-rmd-was-downgraded-to-a-hold-rating-at-needham-1033746911,neutral,0.8161405324935913
554,9/4/2024 6:36:05 PM,Inspire Medical gains on GLP-1 prospects,Seeking Alpha,https://seekingalpha.com/news/4147002-inspire-medical-stock-gains-glp-1-prospects?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9453884959220886
555,9/10/2024 2:00:00 PM,Vaping Expected to Increase COPD Health and Economic Burden by 2050,GlobeNewswire,/news/stocks/vaping-expected-to-increase-copd-health-and-economic-burden-by-2050-1033760121,negative,0.9418618679046631
556,9/10/2024 10:05:00 PM,"ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange",GlobeNewswire,/news/stocks/resmed-to-host-its-2024-investor-day-on-september-30-2024-at-the-new-york-stock-exchange-1033761827,positive,0.9503401517868042
557,9/16/2024 2:49:45 PM,Moderna was most shorted S&P 500 healthcare stock in August for second consecutive month,Seeking Alpha,https://seekingalpha.com/news/4149983-moderna-was-most-shorted-sp-500-healthcare-stock-in-august-for-second-consecutive-month?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8436502814292908
558,9/18/2024 8:46:34 AM,ResMed Faces Market Disruption and Limited Growth: A Sell Rating Analysis,TipRanks,/news/stocks/resmed-faces-market-disruption-and-limited-growth-a-sell-rating-analysis-1033779970,positive,0.5212411284446716
559,9/18/2024 10:16:26 AM,Resmed (RMD) Receives a Hold from Needham,TipRanks,/news/stocks/resmed-rmd-receives-a-hold-from-needham-1033780318,positive,0.8823018074035645
560,9/18/2024 5:25:42 PM,Vivos surges on FDA nod for pediatric sleep apnea device,Seeking Alpha,https://seekingalpha.com/news/4150816-vivos-stock-surges-fda-nod-osa-device?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8012814521789551
561,9/18/2024 6:05:40 PM,ResMed slips as Wolfe downgrades on GLP-1 threat from Lilly,Seeking Alpha,https://seekingalpha.com/news/4150858-resmed-stock-cut-wolfe-lilly-glp-1-threat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9504061937332153
562,9/24/2024 6:18:28 PM,"Baird starts ResMed at outperform, cites growing sleep apnea market",Seeking Alpha,https://seekingalpha.com/news/4152843-baird-starts-resmed-at-outperform-cites-growing-sleep-apnea-market?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8806096315383911
563,9/26/2024 9:17:04 AM,Resmed Poised for Growth Amid Rising OSA Diagnosis and Market Opportunity: Buy Rating Reaffirmed with Increased Price Objective,TipRanks,/news/stocks/resmed-poised-for-growth-amid-rising-osa-diagnosis-and-market-opportunity-buy-rating-reaffirmed-with-increased-price-objective-1033800432,negative,0.9530858397483826
564,9/27/2024 5:30:18 PM,Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA) and Resmed (RMD),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-enanta-pharmaceuticals-enta-and-resmed-rmd-1033804915,positive,0.913774311542511
565,9/27/2024 7:00:37 PM,"Catalyst Watch: Tesla deliveries, Nike earnings, port strike threat and the jobs report",Seeking Alpha,https://seekingalpha.com/news/4154150-catalyst-watch-tesla-deliveries-nike-earnings-and-the-september-jobs-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7818423509597778
566,9/30/2024 2:01:00 PM,ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health,GlobeNewswire,/news/stocks/resmed-unveils-new-collection-of-digital-and-personalized-solutions-designed-to-improve-sleep-health-1033807192,negative,0.6268885135650635
567,9/30/2024 2:10:28 PM,"ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health",GlobeNewswire,/news/stocks/resmed-enhances-cpap-therapy-with-its-first-fabric-mask-designed-to-make-it-easier-for-people-to-embrace-their-treatment-and-improve-overall-sleep-health-1033807338,negative,0.8436893224716187
568,9/30/2024 3:23:15 PM,"UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health",GlobeNewswire,/news/stocks/update-resmed-enhances-cpap-therapy-with-its-first-fabric-mask-designed-to-make-it-easier-for-people-to-embrace-their-treatment-and-improve-overall-sleep-health-1033807609,negative,0.8921301364898682
569,9/30/2024 3:48:43 PM,UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health,GlobeNewswire,/news/stocks/update-resmed-unveils-new-collection-of-digital-and-personalized-solutions-designed-to-improve-sleep-health-1033807992,negative,0.7651318311691284
570,9/30/2024 9:41:29 PM,ResMed '2030 Strategy' aims for high-single-digit revenue growth.,Seeking Alpha,https://seekingalpha.com/news/4154791-resmed-2030-strategy-aims-high-single-digit-revenue-growth?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9054653644561768
571,9/30/2024 10:05:00 PM,"ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns",GlobeNewswire,/news/stocks/resmed-unveils-2030-strategy-to-drive-growth-profitability-and-shareholder-returns-1033809030,negative,0.828449010848999
572,10/1/2024 9:49:51 AM,Needham Reaffirms Their Hold Rating on Resmed (RMD),TipRanks,/news/stocks/needham-reaffirms-their-hold-rating-on-resmed-rmd-1033811125,positive,0.7941057085990906
573,10/1/2024 10:45:59 AM,RBC Capital Sticks to Their Hold Rating for Resmed (RMD),TipRanks,/news/stocks/rbc-capital-sticks-to-their-hold-rating-for-resmed-rmd-1033811476,positive,0.8599727749824524
574,10/1/2024 1:56:05 PM,Bank of America Securities Sticks to Its Buy Rating for Resmed (RMD),TipRanks,/news/stocks/bank-of-america-securities-sticks-to-its-buy-rating-for-resmed-rmd-1033812462,positive,0.888476550579071
575,10/2/2024 2:07:00 PM,Bristol-Myers tops growth chart among S&P 500 healthcare stocks in Q3,Seeking Alpha,https://seekingalpha.com/news/4155316-bristol-myers-tops-growth-chart-among-sp-500-healthcare-stocks-in-q3?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9400187730789185
576,10/3/2024 10:05:00 PM,"ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024",GlobeNewswire,/news/stocks/resmed-to-report-first-quarter-fiscal-2025-earnings-on-october-24-2024-1033819396,positive,0.9455701112747192
577,10/15/2024 6:35:59 PM,Moderna continues to be the most shorted S&P 500 healthcare stock in September,Seeking Alpha,https://seekingalpha.com/news/4162080-moderna-continues-to-be-the-most-shorted-sp-500-healthcare-stock-in-september?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.48144128918647766
578,10/17/2024 10:30:25 AM,Resmed’s Strong Performance and Optimistic Forecasts Drive Buy Rating with USD 270 Target,TipRanks,/news/stocks/resmed-s-strong-performance-and-optimistic-forecasts-drive-buy-rating-with-usd-270-target-1033855718,negative,0.9390754699707031
579,10/17/2024 10:32:01 AM,Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Abbott Laboratories (ABT),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-resmed-rmd-and-abbott-laboratories-abt-1033855705,positive,0.9061751365661621
580,10/23/2024 9:35:25 PM,ResMed Q1 2025 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/4196903-resmed-q1-2025-earnings-preview?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9053460359573364
581,10/24/2024 2:00:00 PM,Here are the major earnings after the close today,Seeking Alpha,https://seekingalpha.com/news/4195372-here-are-the-major-earnings-after-the-close-today?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9299408793449402
582,10/24/2024 7:20:09 PM,ResMed options imply 6.9% move in share price post-earnings,TipRanks,/news/stocks/resmed-options-imply-6-9-move-in-share-price-post-earnings-1033889222,negative,0.694973886013031
583,10/24/2024 8:12:28 PM,"ResMed Non-GAAP EPS of $2.20 beats by $0.16, revenue of $1.22B beats by $40M",Seeking Alpha,https://seekingalpha.com/news/4201914-resmed-non-gaap-eps-of-2_20-beats-0_16-revenue-of-1_22b-beats-40m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7435821294784546
584,10/24/2024 8:16:50 PM,"ResMed reports Q1 non-GAAP EPS $2.20, consensus $2.04",TipRanks,/news/stocks/resmed-reports-q1-non-gaap-eps-2-20-consensus-2-04-1033889363,positive,0.7417784929275513
585,10/24/2024 9:04:44 PM,ResMed rises 5% on Q3 beats,Seeking Alpha,https://seekingalpha.com/news/4202115-res-med-rises-5-q-3-beats?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9434385895729065
586,10/24/2024 10:05:00 PM,ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025,GlobeNewswire,/news/stocks/resmed-inc-announces-results-for-the-first-quarter-of-fiscal-year-2025-1033888754,positive,0.9158722758293152
587,10/24/2024 10:48:27 PM,"Resmed Inc Q1 Profit Increases, Beats Estimates ",RTTNews,/news/stocks/resmed-inc-q1-profit-increases-beats-estimates-1033888986,negative,0.9299346208572388
588,10/24/2024 11:20:19 PM,Closing Bell Movers: Deckers up 12% after earnings beat,TipRanks,/news/stocks/closing-bell-movers-deckers-up-12-after-earnings-beat-1033889730,negative,0.9446895718574524
589,10/25/2024 9:16:31 AM,Resmed (RMD) Gets a Hold from Needham,TipRanks,/news/stocks/resmed-rmd-gets-a-hold-from-needham-1033892401,positive,0.7847260236740112
590,10/25/2024 11:22:25 AM,ResMed price target raised to $283 from $280 at Baird,TipRanks,/news/stocks/resmed-price-target-raised-to-283-from-280-at-baird-1033893461,negative,0.945529043674469
591,10/25/2024 11:52:21 AM,Resmed (RMD) Receives a Buy from KeyBanc,TipRanks,/news/stocks/resmed-rmd-receives-a-buy-from-keybanc-1033893697,positive,0.6164644360542297
592,10/25/2024 12:02:32 PM,Resmed (RMD) Receives a Hold from RBC Capital,TipRanks,/news/stocks/resmed-rmd-receives-a-hold-from-rbc-capital-1033893868,positive,0.8652437329292297
593,10/25/2024 12:07:30 PM,Oppenheimer Reaffirms Their Hold Rating on Resmed (RMD),TipRanks,/news/stocks/oppenheimer-reaffirms-their-hold-rating-on-resmed-rmd-1033893815,positive,0.8619920015335083
594,10/25/2024 12:36:25 PM,ResMed price target raised to $232 from $224 at RBC Capital,TipRanks,/news/stocks/resmed-price-target-raised-to-232-from-224-at-rbc-capital-1033894091,negative,0.9452025294303894
595,10/25/2024 12:36:51 PM,Jefferies Sticks to Their Hold Rating for Resmed (RMD),TipRanks,/news/stocks/jefferies-sticks-to-their-hold-rating-for-resmed-rmd-1033894085,positive,0.8613247275352478
596,10/25/2024 1:20:48 PM,ResMed declares $0.53 dividend,Seeking Alpha,https://seekingalpha.com/news/4204585-resmed-declares-053-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9431967735290527
597,10/25/2024 1:59:25 PM,Bank of America Securities Reaffirms Their Buy Rating on Resmed (RMD),TipRanks,/news/stocks/bank-of-america-securities-reaffirms-their-buy-rating-on-resmed-rmd-1033894683,positive,0.8269631862640381
598,10/25/2024 4:55:48 PM,ResMed price target raised to $266 from $251 at KeyBanc,TipRanks,/news/stocks/resmed-price-target-raised-to-266-from-251-at-keybanc-1033895124,negative,0.9465144276618958
599,10/26/2024 12:05:37 PM,J.P. Morgan Reaffirms Their Buy Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD),TipRanks,/news/stocks/j-p-morgan-reaffirms-their-buy-rating-on-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-rmd-1033895954,positive,0.8048076033592224
600,10/26/2024 12:05:43 PM,J.P. Morgan Sticks to Its Buy Rating for Resmed (RMD),TipRanks,/news/stocks/j-p-morgan-sticks-to-its-buy-rating-for-resmed-rmd-1033895953,positive,0.5810015797615051
601,10/28/2024 12:05:16 AM,Morgans Remains a Buy on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD),TipRanks,/news/stocks/morgans-remains-a-buy-on-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-rmd-1033897023,positive,0.9375903010368347
602,10/29/2024 6:05:36 AM,Wilsons Sticks to Their Buy Rating for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD),TipRanks,/news/stocks/wilsons-sticks-to-their-buy-rating-for-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-rmd-1033907485,positive,0.8402557969093323
603,11/5/2024 10:05:00 PM,ResMed Announces Participation in the UBS Global Healthcare Conference,GlobeNewswire,/news/stocks/resmed-announces-participation-in-the-ubs-global-healthcare-conference-1033954493,positive,0.72125643491745
604,12/12/2024 8:57:05 PM,ResMed launches head strap for Apple's Vision Pro system,Seeking Alpha,https://seekingalpha.com/news/4386070-resmed-launches-head-strap-for-apples-vision-pro-system?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7580485939979553
605,12/12/2024 9:16:31 PM,ResMed initiated with a Hold at Stifel,TipRanks,/news/stocks/resmed-initiated-with-a-hold-at-stifel-1034132431,positive,0.916466474533081
606,12/23/2024 2:32:49 PM,"Biggest stock movers Monday: HMC, XRX, RUM, and more",Seeking Alpha,https://seekingalpha.com/news/4389714-biggest-stock-movers-monday?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9131941795349121
607,1/6/2025 3:00:02 PM,"Healthcare sector's 2024 gainers and losers: Intuitive Surgical, Boston Scientific tops chart",Seeking Alpha,https://seekingalpha.com/news/4392667-healthcare-sectors-2024-gainers-and-losers-intuitive-surgical-boston-scientific-tops-chart?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7643327116966248
608,1/6/2025 10:05:00 PM,ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference,GlobeNewswire,/news/stocks/resmed-announces-participation-in-the-43rd-annual-j-p-morgan-healthcare-conference-1034196847,positive,0.7005771994590759
609,1/8/2025 8:35:29 PM,CMS confirms to CNBC Medicare plans can now cover Zepbound for sleep apnea,TipRanks,/news/stocks/cms-confirms-to-cnbc-medicare-plans-can-now-cover-zepbound-for-sleep-apnea-1034207692,positive,0.7818804979324341
610,1/9/2025 10:05:00 PM,"ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025",GlobeNewswire,/news/stocks/resmed-to-report-second-quarter-fiscal-2025-earnings-on-january-30-2025-1034211585,positive,0.9417084455490112
611,1/10/2025 10:27:15 AM,Balanced Outlook on ResMed: Strong Execution and Innovations Offset by Valuation Concerns and Market Challenges,TipRanks,/news/stocks/balanced-outlook-on-resmed-strong-execution-and-innovations-offset-by-valuation-concerns-and-market-challenges-1034213948,negative,0.9528652429580688
612,1/10/2025 10:45:43 AM,ResMed initiated with a Neutral at Piper Sandler,TipRanks,/news/stocks/resmed-initiated-with-a-neutral-at-piper-sandler-1034214192,positive,0.8764224052429199
613,1/16/2025 10:45:15 AM,ResMed initiated with a Buy at Goldman Sachs,TipRanks,/news/stocks/resmed-initiated-with-a-buy-at-goldman-sachs-1034235318,positive,0.7758362293243408
614,1/16/2025 10:35:09 PM,Citi Keeps Their Hold Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD),TipRanks,/news/stocks/citi-keeps-their-hold-rating-on-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-rmd-1034237898,positive,0.9128830432891846
615,1/21/2025 11:35:16 AM,Resmed Poised for Market Outperformance with Strong Growth Indicators and Strategic Advantages,TipRanks,/news/stocks/resmed-poised-for-market-outperformance-with-strong-growth-indicators-and-strategic-advantages-1034249470,negative,0.9274414777755737
616,1/22/2025 11:05:49 PM,UBS Keeps Their Hold Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD),TipRanks,/news/stocks/ubs-keeps-their-hold-rating-on-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-rmd-1034257164,positive,0.905992865562439
617,1/27/2025 12:08:52 PM,J.P. Morgan Remains a Buy on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD),TipRanks,/news/stocks/j-p-morgan-remains-a-buy-on-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-rmd-1034272425,positive,0.9300429821014404
618,1/29/2025 1:06:33 AM,Jarden Keeps Their Buy Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD),TipRanks,/news/stocks/jarden-keeps-their-buy-rating-on-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-rmd-1034279808,positive,0.9079466462135315
619,1/29/2025 2:35:07 AM,UBS Sticks to Its Hold Rating for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD),TipRanks,/news/stocks/ubs-sticks-to-its-hold-rating-for-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-rmd-1034280630,negative,0.5579549074172974
620,1/29/2025 6:47:41 PM,ResMed Q2 2025 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/4400222-resmed-q2-2025-earnings-preview?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9017425775527954
621,1/30/2025 3:00:00 PM,Here are the major earnings after the close today,Seeking Alpha,https://seekingalpha.com/news/4400080-here-are-the-major-earnings-after-the-close-today?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9299408793449402
622,1/30/2025 9:09:07 PM,"ResMed Non-GAAP EPS of $2.43 beats by $0.12, revenue of $1.28B beats by $10M",Seeking Alpha,https://seekingalpha.com/news/4401070-resmed-non-gaap-eps-of-2_43-beats-by-0_12-revenue-of-1_28b-beats-by-10m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6978590488433838
623,1/30/2025 9:20:51 PM,"ResMed reports Q2 EPS $2.43, consensus $2.31",TipRanks,/news/stocks/resmed-reports-q2-eps-2-43-consensus-2-31-1034291774,positive,0.511805534362793
624,1/30/2025 10:05:00 PM,ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025,GlobeNewswire,/news/stocks/resmed-inc-announces-results-for-the-second-quarter-of-fiscal-year-2025-1034291621,positive,0.914003312587738
625,1/30/2025 10:19:50 PM,"Resmed Inc Q2 Profit Increases, Beats Estimates ",RTTNews,/news/stocks/resmed-inc-q2-profit-increases-beats-estimates-1034291703,negative,0.9347113370895386
626,1/30/2025 10:47:10 PM,Resmed declares fiscal Q2 dividend of $0.53,Seeking Alpha,https://seekingalpha.com/news/4401167-resmed-declares-fiscal-q2-dividend-of-0_53?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.48503008484840393
627,1/31/2025 1:51:58 AM,Resmed (RMD) Gets a Hold from RBC Capital,TipRanks,/news/stocks/resmed-rmd-gets-a-hold-from-rbc-capital-1034292258,positive,0.8601844906806946
628,1/31/2025 8:17:28 AM,Resmed (RMD) Gets a Buy from KeyBanc,TipRanks,/news/stocks/resmed-rmd-gets-a-buy-from-keybanc-1034293857,positive,0.5075790882110596
629,1/31/2025 11:15:19 AM,ResMed price target raised to A$41 from A$38 at Citi,TipRanks,/news/stocks/resmed-price-target-raised-to-a-41-from-a-38-at-citi-1034294712,negative,0.9457082152366638
630,1/31/2025 11:15:36 AM,Neutral Stance on Resmed Inc: Strong Quarterly Performance with Limited Upside Potential,TipRanks,/news/stocks/neutral-stance-on-resmed-inc-strong-quarterly-performance-with-limited-upside-potential-1034294709,negative,0.9409337639808655
631,1/31/2025 11:36:41 AM,Resmed: Hold Rating Amid Growth Deceleration and Emerging Competitive Risks,TipRanks,/news/stocks/resmed-hold-rating-amid-growth-deceleration-and-emerging-competitive-risks-1034294823,neutral,0.9343210458755493
632,1/31/2025 11:45:34 AM,ResMed price target raised to $260 from $252 at Piper Sandler,TipRanks,/news/stocks/resmed-price-target-raised-to-260-from-252-at-piper-sandler-1034294987,negative,0.9470173716545105
633,1/31/2025 11:48:13 AM,Resmed (RMD) Receives a Hold from Piper Sandler,TipRanks,/news/stocks/resmed-rmd-receives-a-hold-from-piper-sandler-1034294957,positive,0.7735727429389954
634,1/31/2025 12:01:42 PM,ResMed price target raised to $280 from $266 at KeyBanc,TipRanks,/news/stocks/resmed-price-target-raised-to-280-from-266-at-keybanc-1034295098,negative,0.9469965100288391
635,1/31/2025 12:47:19 PM,Resmed (RMD) Receives a Hold from Stifel Nicolaus,TipRanks,/news/stocks/resmed-rmd-receives-a-hold-from-stifel-nicolaus-1034295485,positive,0.8359708189964294
636,1/31/2025 1:26:10 PM,ResMed upgraded to Buy from Neutral at UBS,TipRanks,/news/stocks/resmed-upgraded-to-buy-from-neutral-at-ubs-1034295706,negative,0.8574284315109253
637,1/31/2025 1:35:51 PM,ResMed price target raised to $247 from $238 at RBC Capital,TipRanks,/news/stocks/resmed-price-target-raised-to-247-from-238-at-rbc-capital-1034295857,negative,0.9449270963668823
638,1/31/2025 1:37:01 PM,"ResMed upgraded to Buy at UBS as risks skew positive, consensus too cautious",TipRanks,/news/stocks/resmed-upgraded-to-buy-at-ubs-as-risks-skew-positive-consensus-too-cautious-1034295836,negative,0.9325548410415649
639,1/31/2025 1:58:21 PM,Bank of America Securities Keeps Their Buy Rating on Resmed (RMD),TipRanks,/news/stocks/bank-of-america-securities-keeps-their-buy-rating-on-resmed-rmd-1034295925,positive,0.912358283996582
640,1/31/2025 2:35:26 PM,"Zillow initiated, Electronic Arts upgraded: Wall Street’s top analyst calls",TipRanks,/news/stocks/zillow-initiated-electronic-arts-upgraded-wall-street-s-top-analyst-calls-1034296236,positive,0.8164867758750916
641,1/31/2025 5:00:56 PM,"Apple, Intel little changed near noon following earnings: Morning Buzz",TipRanks,/news/stocks/apple-intel-little-changed-near-noon-following-earnings-morning-buzz-1034297283,positive,0.8414871692657471
642,2/3/2025 12:07:23 PM,J.P. Morgan Sticks to Its Buy Rating for Resmed (RMD),TipRanks,/news/stocks/j-p-morgan-sticks-to-its-buy-rating-for-resmed-rmd-1034302898,positive,0.5810015797615051
643,2/3/2025 10:35:31 PM,Morgans Sticks to Their Buy Rating for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD),TipRanks,/news/stocks/morgans-sticks-to-their-buy-rating-for-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-rmd-1034306056,positive,0.7872864603996277
644,2/4/2025 12:06:17 AM,UBS upgrades Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) to a Buy,TipRanks,/news/stocks/ubs-upgrades-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-rmd-to-a-buy-1034306138,negative,0.5323460698127747
645,2/4/2025 12:35:36 AM,Wilsons downgrades Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) to a Hold,TipRanks,/news/stocks/wilsons-downgrades-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-rmd-to-a-hold-1034306169,positive,0.7882744669914246
646,2/4/2025 9:16:14 AM,Goldman Sachs Reaffirms Their Buy Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD),TipRanks,/news/stocks/goldman-sachs-reaffirms-their-buy-rating-on-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-rmd-1034307909,positive,0.8255519866943359
647,2/4/2025 10:35:15 PM,Jarden Remains a Buy on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD),TipRanks,/news/stocks/jarden-remains-a-buy-on-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-rmd-1034311645,positive,0.93885737657547
